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ABSTRACT 
 
 
New Insights into the Roles of Human DNA Damage Checkpoint Protein ATR in the Regulation 
of Nucleotide Excision Repair and DNA Damage-Induced Cell Death 
 
by 
 
Zhengke Li   
 
Integrity of the human genome is frequently threatened by endogenous and exogenous DNA 
damaging reagents that may lead to genome instability and cancer. Cells have evolved multiple 
mechanisms to repair DNA damage or to eliminate the damaged cells beyond repair and to 
prevent diverse diseases. Among these are ataxia telangiectasia and Rad3-related (ATR)-
mediated DNA damage checkpoint and nucleotide excision repair (NER) that are the major 
pathways by which cells handle ultraviolet C (UV-C)- or other exogenous genotoxin-induced 
bulky DNA damage. However, it is unclear how these 2 pathways may be coordinated. In this 
study we show that ATR physically interacts with NER factor xeroderma pigmentosum group A 
(XPA) where an ATR phosphorylation site on serine 196 is located. Phosphorylation of XPA on 
serine 196 is required for repair of UV-induced DNA damage. In addition, a K188A point 
mutation of XPA that disrupts the ATR-XPA interaction inhibits the UV-induced XPA 
phosphorylation and DNA repair. Moreover, we show that depletion of p53, a downstream 
checkpoint of ATR, and inhibition of p53 transcriptional activities reduced the UV-induced XPA 
import. Furthermore, we found that the ATR-directed XPA nuclear import happens primarily in 
the S phase of the cell cycle. In effort to determine the mechanism involved in the XPA nuclear 
import, we found that, in addition to the nuclear localization signal (NLS) of XPA, importin-α4 
is required for the UV-induced XPA nuclear import in an ATR-dependent manner. These data 
suggest that NER could be regulated by the ATR-dependent checkpoint via modulation of XPA 
3 
phosphorylation and nuclear import. In a separate study we show that, upon UV damage, 
cytoplasmic ATR translocates to mitochondria, blocks the recruitment of proapoptotic Bcl-2–
associated X (Bax) protein to mitochondria and prevents the loss of mitochondrial membrane 
potential (ΔΨ) and apoptosis. Bax-depletion reduces the effect of ATR on ΔΨ. Remarkably, the 
cytoplasmic ATR exhibits no checkpoint kinase activity, a hallmark function of nuclear ATR. 
Silencing of ATR’s kinase activity failed to affect Bax relocalization to mitochondria. These 
results reveal a novel checkpoint-independent antiapoptotic function of ATR at mitochondria in 
the cellular response to DNA damage.  
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CHAPTER 1 
 
INTRODUCTION 
 
Human DNA Damage and Cellular Responses 
A high integrity of genomic DNA must be maintained in order to pass on correct genetic 
information to the next generation of cells. However, this integrity is frequently threatened by 
DNA damage induced by endogenous and exogenous genotoxic agents that may cause DNA 
structural changes leading to genomic instability and cancer (1-5). To counter these threats, cells 
have evolved multiple systems to signal DNA damage in order to mediate repair or to eliminate 
the damaged cells that are beyond repair (4, 6-8). Such responses include a wide range of cellular 
events and are biologically crucial because they prevent a series of diseases (5). There are 4 
primary mechanisms that build such responses: DNA damage checkpoint-mediated cell cycle 
arrest, activation of transcriptional programs, DNA repair, and apoptosis (Figure 1-1) (4, 6, 7). 
DNA damage checkpoint proteins sense DNA damage, activate the checkpoint, arrest cell cycle 
progression to give cells sufficient time to remove the damage before the damage can be 
converted to mutations due to error-prone DNA synthesis, and modulate cell fate (6, 9, 10). DNA 
repair removes the damage and restores DNA structural integrity. DNA damage-induced 
apoptosis functions to eliminate cells damaged beyond repair (8, 11, 12). Changes in 
transcriptional programs balance the specific proteins that are needed in these 3 events (7). 
Precise and coordinated functions of these DNA damage responses are required to maintain 
genome integrity and to prevent development of diseases. 
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Figure 1-1. Molecular mechanisms of mammalian DNA damage responses. Modified from 
Sancar et al. 2004 (7) 
 
Damage to DNA can be induced by endogenous or exogenous agents (Figure 1-1), 
generating 3 major types of structural or chemical abnormalities: nucleotide base damage, DNA 
backbone breakages, or DNA cross-links. The type and amount of DNA damage determines 
which DNA damage checkpoint, repair pathway, and apoptotic program is initiated to restore the 
structure of DNA or to promote irreversible cell death (7, 8, 11, 12). My dissertation research has 
focused on the modulation of nucleotide excision repair (NER) via regulation of xeroderma 
pigmentosum group A (XPA) by DNA damage checkpoint protein ataxia telangiectasia and 
Rad3-related (ATR), and the role of ATR in mitochondria-mediated apoptosis pathways. 
Therefore, DNA damage checkpoints, NER, and DNA damage-induced apoptosis are discussed 
primarily in this dissertation.  
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DNA Damage Checkpoints 
The DNA damage checkpoints survey the structural integrity of genomic DNA and 
coordinate multiple cellular pathways to ensure timely and efficient removal of DNA damage (7, 
10, 13-15) or to determine whether cells are damaged beyond repair and should be eliminated (8, 
11, 12). These pathways are comprised of a series of DNA damage sensors, signal mediators, 
and transducers as well as downstream effectors. In mammalian cells 2 major DNA damage 
checkpoint systems are built from the DNA damage checkpoint proteins ataxia telangiectasia 
mutated (ATM) and ATR (16, 17). Both ATM and ATR are protein kinases belonging to the 
phosphoinositide 3-kinase-like kinase (PIKK) family. Activation of these 2 kinases leads to 
phosphorylation of many downstream mediators/effectors which include checkpoint kinase 1 
(Chk1), checkpoint kinase 2 (Chk2), p38/MAPKAP Kinase-2 (MK2), p53, etc. These 
downstream proteins play roles in arresting cell cycle progression (major effects), regulating 
DNA repair and apoptosis (Figure 1-2) (7, 8, 10, 18-20). There is significant cross-talk between 
these two pathways; however, it is currently believed that ATM is primarily activated by DNA 
double-strand breaks while ATR is activated by replication protein A (RPA)-coated single-
stranded DNA (ssDNA) generated from DNA damage-induced replication stresses (7, 10, 21-
23). Notably, ATR is an essential gene (24, 25) while ATM is not. 
 
Figure 1-2. Major mammalian DNA damage checkpoints 
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Genetic diseases found to be associated with ATR mutations include Seckel syndrome 
(26, 27) and oropharyngeal cancer syndrome (28). Seckel syndrome is caused by a single base 
substitution that causes mis-splicing of exon 9 resulting in a lower level of ATR protein (26). 
The selective failure of the brain’s germinal elements in these patients that results in their small 
brains and small heads is a result of defects in ATR-dependent DNA damage signaling leading to 
the premature death of proliferating cells (26, 29, 30). Interestingly, cells from oropharyngeal 
cancer syndrome patients have normal ATR protein level; relative ATR kinase activity towards 
downstream proteins is also normal. To date, the only abnormality observed in the oropharyngeal 
cancer syndrome cells is a lower level of the DNA damage-induced increase of p53 due to 
heterozygous missense mutation in ATR (28). Additionally, somatic mutations in exon 10 of the 
ATR gene are found in endometrial, colon, and stomach tumors (30, 31). Mutations in ATM lead 
to ataxia telangiectasia (A-T), an autosomal recessive neurodegenerative disease characterized 
by cancer proneness, telangiectasia, immunodeficiency, and extreme radiosensitivity (32, 33).  
 
Nucleotide Excision Repair (NER) 
In mammals the NER pathway is the major mechanism for the removal of helix-
distorting, replication-blocking bulky DNA adducts that are induced by exogenous agents such 
as UV irradiation and a variety of genotoxic chemicals (7, 14). NER is the primary mechanism 
preventing potential mutations resulting from UV irradiation that induces DNA damage mostly 
in the form of cyclobutane pyrimidine dimers (CPDs) and 6, 4 photoproducts (6-4PPs) (7, 34-
36). NER can be divided into 2 subpathways according to whether the damage occurs in 
transcriptionally active or inactive regions of the genome: transcription-coupled NER (TC-NER) 
or global genomic NER (GG-NER) (Figure 1-3). The 2 subpathways differ only in their method 
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of DNA damage recognition. In TC-NER recognition is initiated by stalled RNA polymerase II 
(RNAPII) in a process involving the Cockayne syndrome B (CSB) and CSA protein complex. In 
the GG-NER the damaged DNA is recognized by the xeroderma pigmentosum group C (XPC) 
that is facilitated by XPE (complex of UV-damaged DNA-binding proteins (DDB) 1 and 2). 
Following recognition, the 2 subpathways merge into a common mechanism starting with the 
unwinding of DNA containing the lesion, removal of the damaged DNA strand, and creation of a 
single-strand gap that is subsequently filled by DNA polymerase using the undamaged strand as 
a template. 
 
Figure 1-3. Nucleotide excision repair pathways. Modified from Cleaver et al. 2009 (37) 
 
In humans deficiency in 11 of the approximately 30 total NER proteins can lead to a 
severe cancer-prone disease Xeroderma pigmentosum (XP) (38-40) or to premature aging-like 
disorders including Cockayne syndrome (CS) and trichothiodystrophy (TTD) (37, 41). Most 
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patients with XP, such as patients with a xeroderma pigmentosum complementation group A 
(XPA) deficiency, have defects in both GG-NER and TC-NER and are characterized by extreme 
photosensitivity and a 1000-fold increased risk of skin cancer (36, 38, 41). Patients with CS or 
TTD have defects in TC-NER (36, 41). A hallmark of all of these syndromes is hypersensitivity 
to UV-irradiation resulting from defective repair of UV-induced DNA damage by NER. 
 
DNA Damage-Induced Apoptotic Cell Death 
There are 2 major outcomes from DNA damage: the damage is removed / tolerated or the 
cells that harbor damages are eliminated by apoptosis. Given that DNA damage checkpoints and 
DNA repair are the primary mechanisms for removing DNA damage, the regulated apoptotic cell 
death is fundamental in eliminating cells harboring DNA damage (8, 11, 12). To date research 
indicates that there are 2 main apoptotic pathways (42-44): the extrinsic cell death receptor 
pathway and the intrinsic mitochondrial pathway. Each pathway activates its own initiator 
procaspases (cysteine-dependent aspartate-directed proteases that exist as inactive proenzymes) 
that activate other procaspases allowing for the initiation of an irreversible commitment towards 
cell death. 
A central player in DNA damage-induced apoptosis is the tumor suppressor p53. DNA 
damage-induced intrinsic apoptosis can be divided into 2 pathways according to the involvement 
of p53: p53-dependent and p53-independent apoptosis (8, 11, 12). In the p53-dependent 
apoptotic pathways, p53 plays a direct role through relocalization to mitochondria (45, 46) 
and/or interacting with apoptotic proteins (47), or it works indirectly by transcriptional activation 
of apoptotic genes (8, 11, 12, 47). Cells also can trigger p53-independent apoptosis pathways: (i) 
p53 function can be replaced by the homologs such as p63 and p73 (48, 49) and (ii) apoptosis 
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that is initiated by transcriptional inhibition (50), transcription factor nuclear factor-kB (NF-kB) 
(51), B-cell lymphoma 2 (Bcl-2) degradation (52, 53), caspase-2  (54-56), or caspase-3 (52, 57, 
58). With regard to diseases, inappropriate apoptosis is involved in many human diseases 
including neurodegenerative diseases, ischemic damage, autoimmune disorders, and cancer (42-
44). 
The ATM and ATR-dependent DNA damage checkpoint pathways are thought to be the 
key nodes in making the decision between survival and death following genotoxic stresses (8, 11, 
12, 59). Many proteins are phosphorylated by these 2 kinases (60) and cell death decisions can 
be conducted by those involved in apoptotic pathways (8, 11, 12).  
 
DNA Damage Checkpoint Protein Ataxia Telangiectasia and Rad3-Related (ATR) 
Serine/Threonine Kinase 
ATR is a member of the phosphoinositide 3-kinase-like kinase (PIKK) family. Its kinase 
activity has a strong preference for serine or threonine residues that are followed by a glutamine 
(“S/TQ” sites) (61). The full activation of this kinase requires the localization of the ATR-
ATRIP (ATR-interacting protein) complex to the RPA-coated ssDNA, as well as other regulators 
including TopBP1 (DNA topoisomerase 2-binding protein 1) (62, 63), 9-1-1 complex (Rad9-
Rad1-Hus1 proteins) (64, 65) and RHINO (RAD9, HUS1, RAD1-interacting nuclear orphan 
protein) (66). Following activation, ATR phosphorylates hundreds of downstream proteins that 
arrest the cell cycle and maintain cell survival (22, 25, 60, 67-69).  
Unfortunately, there is currently no high-resolution structural data available for ATR. 
Nonetheless, the domain architecture of ATR is similar to other PIKKs based on their sequence 
similarity (Figure 1-4) (22, 68-70). The kinase domain is flanked by the FAT 
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(FRAP/ATM/TRAP) and FATC (FAT C-terminal) domains. A regulatory domain (PRD) is 
between the kinase and FATC domain, which has demonstrated regulatory roles in ATR 
activations (62). The N-terminal region of ATR contains multiple α-helical HEAT repeats 
(Huntingtin, elongation factor 3, protein phosphatase 2A and yeast TOR1) that are currently 
believed to play a common structural role in coordinating protein interactions (71). In humans 
the N-terminus of ATR is associated with ATRIP (ATR-interacting protein). As a protein 
partner, ATRIP interaction is required for the function of ATR as a kinase (21, 72). 
 
Figure 1-4. A map of ATR’s functional domains. Numbers indicate amino acid regions. 
Modified from Cimprich et al. 2008 (69) 
 
Functions in DNA Repair 
ATR-mediated DNA damage checkpoint is anticipated to arrest the cell cycle and allows 
cells to have time to repair DNA damage (7, 10, 14). It is therefore expected that cross-talk exists 
between ATR signaling and DNA repair pathways (14); however, how these 2 pathways are 
coordinated is still largely unclear. It appears now, though, that ATR is a master controller of 
NER during S phase of the cell cycle (15). Previous studies have implied a role for the ATR-
mediated checkpoint pathway in regulation of the NER pathway (73-75). In particular, ATR 
kinase activity may participate in the regulation of GG-NER during the S phase of the cell cycle. 
The NER protein XPA has been defined as a direct target for phosphorylation by ATR following 
UV irradiation, and UV-induced cytoplasm-to-nucleus redistribution of XPA depends on ATR 
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(73, 74). XPA is required for both TC-NER and GG-NER (76, 77) and has been proposed as a 
rate-limiting factor for human NER activity (78-80). XPA
−/−
 cells complemented with 
recombinant phosphorylation-deficient XPA protein displayed an increased sensitivity to UV-C 
irradiation compared with cells complemented with wild-type XPA (73); furthermore, inhibition 
or knockdown of ATR delayed repair of UV-induced DNA damage (74, 75). In addition to its 
functions in NER, ATR regulates inter-strand crosslink repair by phosphorylation of FANCD2 
(Fanconi anemia group D2) (81); ATR phosphorylates several proteins needed in recombination 
(82-84). 
 
Regulation of DNA Replication 
ATR is an essential gene as evidenced by the fact that knockout of ATR in mice is 
embryonically lethal (25, 85) and cells generated from these ATR-knockout mice die of 
apoptosis (25, 72). There are several mechanisms proposed by which ATR can regulate DNA 
replication in the absence of exogenous stresses (71, 86). These mechanisms include: control of 
replication initiation by regulating timing of origin firing (87-89), monitoring of replication 
progression (90-93), prevention of premature chromatin condensation and entry into mitosis 
without completion of DNA replication (94-97), and/or protection from the accumulation of 
DNA breaks associated with replication (98, 99).  
 
Antiapoptotic Functions of ATR in DNA Damage Responses 
In contrast to ATM, ATR is essential for viability of mice and the cells from ATR-
knockout mice died of apoptosis (25, 85, 100). Furthermore, inhibition of ATR enhanced 
apoptosis through a p53-independent mechanism (58, 101-105) regardless of ATR’s kinase 
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activation in some cancer cells (105), and suppressed UV-induced carcinogenesis (102, 103). 
Also interestingly, a body of evidence from human epidemiologic and mouse model studies has 
demonstrated that caffeine consumption significantly decreased the risk of cancer (24, 106-116). 
Notably, caffeine is an inhibitor of cell cycle checkpoint pathways (111), but the inhibition may 
be independent of the kinase activities of ATM or ATR (117). Together the current evidence 
suggests that unlike ATM, ATR may contain an antiapoptotic activity and inhibition of ATR 
suppresses carcinogenesis. However, the molecular mechanism remains unknown. Given the 
potential antitumor activity of ATR inhibition, ATR has drawn attention as a promising target for 
anticancer chemotherapy, further underscoring the importance for understanding the mechanism. 
In this dissertation study, our data revealed a possibility that ATR also may have cytoplasmic 
functions in the mitochondria-mediated apoptosis pathways. 
  
Regulation by Posttranslational Modifications 
Posttranslational modifications of ATM are important markers for studying the ATM-
mediated signaling pathways (118). Therefore, it is anticipated that posttranslational 
modification of ATR also may serve as an indicator for ATR activation that could be enormously 
useful, as previous approaches to monitor ATR signaling relies solely on assessment of its 
downstream substrates (22, 69). In recent studies 2 groups identified auto-phosphorylation of 
ATR on Thr-1989 (70, 119) which could serve as a marker for ATR kinase. The Thr-1989 
phosphorylation of ATR is induced by DNA damage in an ATR kinase-dependent manner. 
Compared with cells complemented with wild type ATR, cells expressing the non-
phosphorylatable ATR (T1989A) mutant exhibit modest ATR functional defects (70). More 
detailed studies show that this phosphorylation of ATR is dependent on RPA and ATRIP and is 
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recognized by TopBP1 to facilitate ATR substrate recognition (119). Interestingly and 
importantly, this phosphorylation of ATR, together with a later report of other 16 potential 
autophosphorylation sites of ATR (120), does not alter its migration in sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). In this study we found a DNA damage-
induced migratory change of cytoplasmic ATR (possible novel modifications on ATR) that has 
important antiapoptotic roles in DNA damage responses. 
 
DNA Damage-Induced Phosphorylation and Nuclear Import of Xeroderma Pigmentosum Group 
A (XPA) 
The XPA protein is 1 of 8 factors that were found to be deficient in XP disorders (121), 
and XPA-deficient cells exhibit the highest UV sensitivity among the XP cells (122). XPA is an 
indispensable factor for both TC-NER and GG-NER (76, 77) (Figure 1-3). Because of XPA’s 
crucial functions in NER, the activity of NER and sensitization of cancer cells to chemotherapy 
can be regulated by transcriptional and posttranscriptional control of the XPA protein (73, 74, 
78-80, 123). Functionally, XPA is believed to play roles in verifying DNA damage, stabilizing 
repair intermediates, and recruiting other NER factors to the damaged DNA (76, 124-131). To 
accomplish these functions XPA protein contains multiple functional domains and interacts with 
various other proteins, including replication protein A (RPA), ERCC1, DNA damage-binding 
protein 2 (DDB2), and transcription factor II H (TFIIH), as well as with chemical carcinogen-
damaged or UV-damaged DNA (Figure 1-5) (131).  
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Figure 1-5. A map of XPA protein illustrating the locations of the binding sites for various DDR 
proteins or for binding damaged DNA. Modified from ref Bartels et al. 2007 (131) 
 
Extensive studies have been dedicated to understand the transcriptional and 
posttranscriptional regulation of XPA protein with a hope to manipulate the activity of NER 
because NER is responsible for removal of DNA damage introduced by chemotherapeutic 
agents. Manipulation of NER has potential benefits in anticancer therapy (78-80, 123, 132). 
Previous studies indicate that ATR directed a time- and dose-dependent cytosol-to-nucleus 
redistribution of XPA in response to UV irradiation (74). This damage-induced translocation of 
XPA is dependent on ATR as a checkpoint because inhibition of ATR’s kinase activity inhibited 
XPA nuclear import (74). Furthermore, inhibition or knockdown of ATR inhibited 
phosphorylation of XPA (73) as well as NER activity (73, 75, 133). These findings lead us to 
propose that ATR regulation of XPA nuclear importation and/or phosphorylation may coordinate 
the ATR checkpoint activity with NER. The details of the ATR-directed XPA nuclear import and 
the roles of ATR-mediated XPA phosphorylation, however, are still unknown and are part of the 
research presented in this dissertation. 
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Questions to be Answered in the Studies 
In our previous studies we found that ATR directly binds to and phosphorylates XPA in 
an UV-dependent manner (73). In addition, the ATR-mediated DNA damage checkpoints direct 
the nuclear import of XPA in response to UV-irradiation. A clear interaction between ATR and 
XPA has been established, and there is growing evidence that the ATR-dependent checkpoint 
pathway coordinates with NER via regulation of XPA subcellular localization and/or 
phosphorylation to promote DNA repair. However, whether the phosphorylation of XPA by 
ATR is required for removal of UV-induced DNA damage (73); as well as how the ATR-XPA 
interaction (73) occurs and its significance have not been defined.  The molecular basis of the 
ATR-XPA interaction remains to be elucidated as there is no structural information available for 
the ATR kinase domain or a model for how it binds to target proteins. Using a mass 
spectrometry-based protein footprinting method, a former lab member (Steven M. Shell) found 
that ATR interacts with a helix-turn-helix (HTH) motif in the minimal DNA binding domain of 
XPA where an ATR phosphorylation site (serine 196) is located. I continued this avenue of 
research and investigated whether this ATR interaction and/or phosphorylation of XPA is 
required for DNA repair. This work has been published in the Journal of Biological Chemistry 
(2009, 284(36): 24213-22) and is presented here as Chapter 2 (134).  
After we published our initial work on the regulation of NER via posttranslational 
regulation of XPA by ATR, another group reported a requirement of ATR in maintaining NER 
activity primarily during S phase in human cells (15, 75). This leads to additional questions: (1) 
is the ATR-directed nuclear import of XPA upon DNA damage also cell cycle specific; (2) are 
any of ATR downstream targets involved in the UV-induced XPA import? To address these 
questions, human cells were synchronized, and the nuclear import of XPA as well as NER 
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activity was measured. The dependence of XPA nuclear import on the ATR’s major 
phosphorylation targets such as p53, Chk1, and MK2 also were investigated. We demonstrated 
that the XPA-mediated regulation of NER by ATR is p53-dependent and occurs primarily in S 
phase. This work has been published in PLoS ONE (2011, 6(12): e28326) and is presented here 
as Chapter 3 (135). 
Given the important nuclear functions of XPA in NER (7, 136) as well as the fact that 
targeting protein trafficking could be a strategy to improve the sensitivity of cancer cells to 
chemotherapeutic agents (137), it is of interest to study the DNA damage-dependent nuclear 
import of XPA (74, 135, 138). We have established that DNA damage-induced nuclear import of 
XPA from the cytoplasm, for NER during S phase, is mediated by DNA damage checkpoint 
proteins ATR and p53 (74, 135). However, despite the importance of XPA nuclear import in 
NER, how XPA is imported through the nuclear pore complex (NPC) remains unknown. In a 
separate study, protein factors potentially involved in the nuclear import XPA were investigated. 
We found that in addition to dependence on the nuclear localization signal (NLS) of XPA, 
importin-α4 and importin-α7 are required for the XPA nuclear import. This manuscript is 
published in PLoS ONE (2013, 8(7): e68297) and is presented here as Chapter 4. 
Our recent data suggests that UV-induced XPA nuclear import is regulated by ATR 
through a p53 signaling pathway (135). Given that p53-deficient cancer cells rely on the 
p38MAPK/MK2 pathway for survival of DNA damages rather than the ATR/p53 signaling 
pathway (19, 139), it is of interest to determine whether the DNA damage-induced XPA nuclear 
import occurs in p53 deficient cancer cells and whether the import is regulated by different 
pathways in p53-proficient and deficient cancer cells. In addition, cisplatin is one of the 3 most 
commonly used chemotherapeutic drugs (140). NER-mediated repair of cisplatin-induced DNA 
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damage is a major factor in modulating the therapeutic efficacy of cisplatin (141, 142). 
Therefore, the status of NER is an important factor in the success of chemotherapy using 
cisplatin (142, 143), which makes it interesting to study whether cisplatin also induces a nuclear 
import of XPA. Interestingly, our finding indicates that although the ATR dependence of XPA 
nuclear import occurs in p53-proficient normal and cancer cells treated with cisplatin or UV, it 
does not happens in p53-deficient lung cancer cells such as H1299 cells. This work is published 
in the Int J Biochem Mol Biol. 2(2): 138-145 and is presented as Chapter 5 (138). 
ATR has been shown to have antiapoptotic functions in replicative stress response (58, 
101-105, 144); however, the mechanism by which it carries out its intrinsic apoptotic functions is 
not well defined. ATR-mediated regulation of checkpoints p21 and Chk1 contribute to its 
antiapoptotic function (102, 144). Interestingly, ATR also was suggested to have kinase-
independent antiapoptotic roles in sensitization of cells to DNA damage (105). In addition to its 
antiapoptotic functions in cells treated with exogenous DNA damaging agents, there are lines of 
evidence showing possible proapoptotic function of ATR when cells fail in initiating DNA 
replication (57, 145). However, it was not clear to us how ATR carries out its intrinsic roles in 
apoptosis. We reasoned that ATR may have a role in the mitochondria-mediated apoptotic 
pathways. As a novel finding, our results suggest a role for ATR in regulating mitochondrial 
membrane potential/apoptosis via kinase-independent inhibition of Bax relocalization to the 
mitochondria. This manuscript is in submission and is presented here as Chapter 6. 
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Abstract 
In response to DNA damage, eukaryotic cells activate a series of DNA damage-
dependent pathways that serve to arrest cell cycle progression and remove DNA damage. 
Coordination of cell cycle arrest and damage repair is critical for maintenance of genomic 
stability. However, this process is still poorly understood. Nucleotide excision repair (NER) and 
the ATR-dependent cell cycle checkpoint are the major pathways responsible for repair of UV-
induced DNA damage. Here we show that ATR physically interacts with the NER factor 
xeroderma pigmentosum group A (XPA). Using a mass spectrometry-based protein footprinting 
method, we found that ATR interacts with a helix turn-helix motif in the minimal DNA-binding 
domain of XPA where an ATR phosphorylation site (serine 196) is located. XPA-deficient cells 
complemented with XPA containing a point mutation of S196A displayed a reduced repair 
efficiency of cyclobutane pyrimidine dimers as compared with cells complemented with wild-
type XPA, although no effect was observed for repair of (6-4) photoproducts. This suggests that 
the ATR-dependent phosphorylation of XPA may promote NER repair of persistent DNA 
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damage. In addition, a K188A point mutation of XPA that disrupts the ATR-XPA interaction 
inhibits the nuclear import of XPA after UV irradiation and, thus, significantly reduced DNA 
repair efficiency. By contrast, the S196A mutation has no effect on XPA nuclear translocation. 
Taken together, our results suggest that the ATR-XPA interaction mediated by the helix-turn-
helix motif of XPA plays an important role in DNA-damage responses to promote cell survival 
and genomic stability after UV irradiation.  
 
Introduction 
NER is the primary mechanism in mammalian cells for the removal of bulky DNA 
lesions induced by exogenous agents such as UV radiation and a variety of genotoxic chemicals 
(7). In eukaryotic cells NER requires more than 25 proteins to perform the DNA damage 
recognition, excision, and DNA synthesis steps necessary to remove the lesion and restore the 
integrity of DNA (146, 147). In humans, defects in NER lead to the clinical disorder xeroderma 
pigmentosum (XP) that is characterized by increased sensitivity to UV light and a predisposition 
to development of skin cancer (38-40).  
Xeroderma pigmentosum group A protein (XPA) is one of eight factors found to be 
deficient in XP disorder (121). XPA is a 32-kDa zinc metalloprotein that is believed to verify the 
damage site after initial recognition of the presence of a lesion, stabilize repair intermediates, and 
play a role in recruiting other NER factors (76, 124-130). XPA is an indispensable factor for both 
the transcription-coupled repair and global genome NER pathways (76, 77). Given its central 
role in NER, patients with XPA deficiency display the most severe XP phenotypes (121, 147). In 
addition, XPA also has been implicated to play a role in laminopathy-induced premature aging 
syndromes (148, 149).  
31 
The DNA damage checkpoint pathways serve to monitor genomic integrity and to 
coordinate multiple cellular pathways to ensure efficient repair of DNA damage (13). The ATM 
(ataxia-telangiectasia mutated) and ATR (ATM and RAD3-related)-mediated checkpoint 
pathways represent two major DNA damage-dependent checkpoints. Both ATM and ATR are 
protein kinases belonging to the phosphoinositide 3-kinase-like kinase family. These pathways 
are composed of a series of DNA damage sensors, signal mediators and transducers, and 
downstream effector molecules (7, 13, 74). The ATR-dependent checkpoint pathway serves to 
sense replication stress and responds primarily to DNA damage typically generated by UV 
irradiation (7, 18, 21, 150). ATR is targeted to the sites of elongated RPA-coated single-strand 
DNA generated when DNA replication forks stall because of DNA damage. This event is 
mediated by interactions between RPA and the ATR interaction protein ATRIP (21). Upon 
sensing DNA damage, ATR initiates a complex signaling cascade via phosphorylation of 
downstream protein substrates, which ultimately leads to cell cycle arrest (7, 18, 20).  
Previous studies have implied a role for the ATR-mediated checkpoint pathway in 
regulation of the NER pathway (73-75). In particular, ATR kinase activity may participate in the 
regulation of global genome NER uniquely during the S phase of the cell cycle. Additionally, 
XPA has been defined as a direct ATR target for phosphorylation and cytoplasm-to-nucleus 
redistribution in response to UV-C irradiation (73, 74). XPA
−/−
 cells complemented with 
recombinant phosphorylation-deficient XPA protein displayed an increased sensitivity to UV-C 
irradiation compared with cells complemented with wild-type XPA (73). In addition, ATR 
directed the nuclear import of XPA in both a dose-dependent and time-dependent manner for 
regulation of NER activity (74).  
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Although there is growing evidence that the ATR-dependent checkpoint pathway 
coordinates with NER via an ATR-XPA interaction to promote DNA repair, how the interaction 
occurs and its significance have not been defined. Furthermore, the molecular basis of the ATR-
XPA interaction remains to be elucidated. There is no structural information available for the 
ATR kinase or a model for how it binds to target proteins. In this study we investigated the 
molecular basis for the ATR-XPA interaction. Using our mass spectrometric protein footprinting 
technique, we identified an α-helix in the XPA minimum DNA-binding domain that mediates the 
XPA-ATR interaction. In addition, we demonstrate that regulation of XPA activity by ATR via 
ATR-XPA interaction is required for promoting repair of UV-C induced DNA damage by NER.  
 
Materials and Methods 
Cell Lines and Tissue Culture  
XPA
−/−
 cells (GM04429) were obtained from Coriell Cell Repositories (Camden, NJ) and 
were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine 
serum and 1% penicillin-streptomycin. XPA-complemented cells were generated by stably 
transfecting GM04429 cells with pcDNA3.1 vectors (Invitrogen) containing either wild-type or 
mutated XPA cDNA with the indicated point mutations as described previously (73). U2OS 
stably transfected with the doxycycline-inducible FLAG-tagged ATR expression construct were 
a generous gift from Dr. Paul Nghiem (University of Washington Medical Center) and were 
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 
1% penicillin-streptomycin, 0.2 mg/ml neomycin, and 0.2 mg/ml hygromycin. All cell lines were 
grown at 37 °C, 5% CO2. UV-C irradiation was performed using a 254-nm lamp at a fluence of 
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1.3 J/m
2
/s. For time course analysis cells were incubate at 37 °C, 5% CO2 for the indicated 
amounts of time. 
FLAG-ATR Immunoprecipitation and ATR-XPA Complex Formation 
U2OS-FLAG-ATR cells were grown overnight in 10-cm tissue culture dishes in 
Dulbecco's modified Eagle's medium supplemented with doxycycline (5 μg/ml). Cells were 
harvested by scraping and resuspended in lysis buffer (50 mM HEPES-KOH, pH 7.4, 150 mM 
NaCl, 1 mM EDTA, 1% Triton X-100, 1× protease inhibitor mixture (Roche Applied Science)). 
Clarified lysates were immunoprecipitated using monoclonal mouse-anti-FLAG M2 antibody 
(Sigma) and captured with Protein G-coated Sepharose beads (Amersham Biosciences). Beads 
were rinsed with wash buffer A (50 mM HEPES-KOH, pH 7.4, 150 mM NaCl, 1 mM EDTA, 
0.05% NP-20) before washing with high salt buffer (50 mM HEPES-KOH, pH 7.4, 1 M NaCl, 1 
mM EDTA, 0.05% Nonidet P-40). Immunoprecipitates then were equilibrated in the XPA-ATR 
binding buffer (50 mM HEPES-KOH, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM ATP), and 
purified His6-XPA was added and incubated at room temperature for 30 min. Unbound XPA was 
washed away using buffer B (50 mM HEPES-KOH, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM 
ATP, 0.05% Nonidet P-40). The resulting complex was modified by the addition of NHS-biotin 
(1 mM final concentration) for 30 min. The reactions were quenched with 10 mM lysine in its 
free form. The interacting proteins were separated by SDS-PAGE and visualized by Coomassie 
stain. The XPA bands were excised from the gel and subjected to in-gel trypsin hydrolysis. 
Mass Spectrometric Analysis 
The tryptic peptide fragments were analyzed with matrix-assisted laser desorption time-
of-flight (MALDI-TOF) mass spectrometry using an Axima-CRF instrument (Shimadzu 
Scientific Instruments). Samples were ionized with an α-cyano-4-hydroxycinnamic acid matrix. 
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To identify XPA peptide peaks, the experimental data were compared with the theoretical values 
obtained with Protein Prospector Version 4.0.6. The experimental measurements indicated the 
mass accuracy of 0.1–0.01%. Modified lysine residues were assigned by identifying the peptide 
peaks formed upon the NHS-biotin treatment of the protein. The experimental mass/charge data 
for modified peptides were then compared with the predicted theoretical values considering that 
each modification adds 226 Da to the affected Lys and renders the residue resistant to tryptic 
hydrolysis. For accurate quantitative analysis of the modified peptide peaks, at least two 
unmodified proteolytic peptide peaks were used as internal controls. A protection was considered 
to be significant when the intensity of the given modified peptide peak derived from NHS-biotin-
treated free protein was reduced at least 10-fold in the context of the protein-protein complex. A 
modified peptide peak was considered unprotected when the intensities of the given peptide 
obtained from free protein and protein-protein complexes were within ±20% of each other. The 
data were reproducibly compiled and analyzed from at least four independent experimental 
groups.  
Co-Immunoprecipitation  
Coimmunoprecipitation experiments were conducted by lysing cells with lysis buffer A 
and adding dilution buffer to reduce the final NaCl concentration to 150 mM. One mg of total 
protein was immunoprecipitated using 2 μg of monoclonal mouse-anti-XPA (Clone 12FA, 
Kamiya Biochemical) or anti-ATR antibody (A300-137A, Bethyl). Samples were resolved on a 
4–12% gradient SDS-PAGE for western blot analysis. 
Immunofluorescent DNA Repair Assay  
For immunofluorescence microscopy, cells were grown on coverslips and UV-C-
irradiated through 3- or 5-μm polycarbonate isopore filters (Millipore) and allowed to recover for 
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the indicated amounts of time. Cells were fixed with 100% methanol and treated with 1 M HCl 
to denature the DNA. Cyclobutane pyrimidine dimers (CPD) or (6-4) photoproducts ((6-4)PPs) 
were detected with monoclonal mouse-anti-CPD (TDM-2, MBL International Corporation) or 
anti-(6-4)PPs (D195–1, MBL) and donkey-anti-mouse Alexa Fluor 568 antibodies (Molecular 
Probes). Coverslips were mounted in ProLong Antifade with DAPI (Molecular Probes) and 
visualized using 100× magnification. Data were recorded under single-blind conditions in which 
the individual performing the microscopy did not know the identity of the samples. Repair of 
CPD or (6-4)PPs damage was quantified as a percentage of DAPI-stained nuclei containing at 
least one well defined CPD or (6-4)PPs focus by overlaying the anti-CPD or anti-(6-4)PPs and 
DAPI images. At least 50 nuclei per time point were counted for damage repair quantification. 
Samples then were normalized, with time point 0 h representing 100% nuclei containing CPD or 
(6-4)PPs foci. Images were analyzed using Photoshop CS. 
Slot-blot DNA Damage Repair Assay  
Cells were seeded at 1 × 10
6
 cells per 10-cm tissue culture dish and allowed to grow for 
48 h before UV-C irradiation. Cells were allowed to recover for the indicated amounts of time, 
and genomic DNA was purified using the PureLink Genomic DNA kit (Invitrogen). Purified 
DNA was quantified by measuring the A260 nm, and samples were diluted to 0.2 μg/ml in a final 
volume of 200 μl of TE buffer containing 10 mM Tris-HCl, pH 7.4, and 1 mM EDTA. Samples 
were denatured by incubating at 90 °C for 10 min then rapidly chilled on ice for 10 min before 
adding an equal volume of 2 M ammonium acetate. Samples were filter-immobilized on a nylon 
membrane and probed using monoclonal mouse-anti-CPD. 
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Subcellular Fractionation  
The subcellular protein fractionation was performed using the Proteo JET
TM
 cytoplasmic 
and nuclear protein extraction kit (Fermentas) and by following the procedures as suggested by 
the manufacturer. Briefly, 10 volumes of cell lysis buffer (with protease inhibitors) were added 
to 1 volume of packed cells. After vortexing for 10 s and incubation on ice for 10 min, 
cytoplasmic proteins were separated from nuclei by centrifugation at 500 × g for 7 min. Isolated 
nuclei were washed once with 500 μl of the nuclei washing buffer and then collected by 
centrifugation. The collected nuclear pellets were resuspended in ice-cold nuclear storage buffer, 
and 1/10 volume of the nuclear lysis reagents were added to the mixtures to lysis the nuclei by 
shaking for 15 min at 4 °C. Then nuclear lysate was collected after rinsing by centrifugation at 
20,000 × g for 12 min. 
 
Results 
Mass Spectrometric Footprinting of the XPA-ATR Complex 
To form the protein-protein complex, purified His6-XPA was added in excess to FLAG-
ATR immobilized on Protein-G beads and incubated in the binding buffer (see “Materials and 
Methods”). For control experiments, XPA was also incubated with the Protein-G beads that were 
preincubated with anti-FLAG-treated cell lysates from un-induced U2OS cells under the same 
experimental conditions. Unbound XPA was then washed away, and the resulting samples were 
treated with NHS-biotin. In parallel experiments, free XPA was also subjected to the NHS-biotin 
treatment. The modified proteins were then resolved by SDS-PAGE. The XPA bands were 
excised from the gel and subjected to in-gel trypsin proteolysis to generate small peptide 
fragments amenable for MALDI-TOF analysis. To identify the XPA surface lysine(s) interacting 
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with ATR, we compared the modification profiles of free XPA and the XPA-ATR complex. 
Figure 2-1 depicts representative MALDI-TOF fragment profiles used for comparison. Figure 2-
1A demonstrates that Lys-188 was readily susceptible to modification in free XPA but was 
inaccessible to NHS-biotin in the XPA-ATR complex. These results indicate that Lys-188 is 
surface-exposed in free XPA and becomes shielded upon ATR binding. In contrast, Figure 2-1B 
illustrates an m/z peak corresponding to biotinylated XPA fragment 31-32 (K31+ biotin) present 
in the spectra for both the free XPA and the XPA-ATR complex. These data suggest that surface 
topology of Lys-31 is not affected by the bound ATR. Peaks C1, C2, and C3 are unmodified 
peptide peaks of XPA and provide internal reference. The lysine foot-printing results for the 
XPA-ATR complex are summarized in Table 2-1: 16 lysine residues were biotinylated in XPA, 
of which one residue, Lys-188, was protected from modification in the presence of ATR. 
 
Figure 2-1. MALDI-TOF analysis of lysine protection in the XPA-ATR complex  
A, top and middle spectra show free XPA and the XPA-ATR complex treated with NHS-biotin. 
The bottom spectrum shows untreated free XPA. The peak corresponding to XPA tryptic peptide 
fragment amino acids 184–189 containing a single modified Lys at position 188 is indicated. 
This peak is detected in free XPA samples and is significantly diminished in the XPA-ATR 
complex. B, unlike Lys-188, lysine residue 31 is modified in both free XPA and the XPA-ATR 
38 
complex. Peaks C1, C2, and C3 are unmodified peptide fragments of XPA and serve as internal 
controls. Data in this Figure were generated by Steven M. Shell. 
 
Table 2-1. Summary of MALDI-TOF analysis of biotinylated XPA peptides 
Presented are tryptic digest fragments containing biotinylated lysine residues. Lysine residues 
protected from modification in the presence of ATR are indicated by a 
_
, whereas residues not 
protected by ATR are indicated by a +. The asterisk indicates that the biotinylated fragment is 
located in the His tag. The intensity of the biotinylated peptide peak 184–189 (Lys-188 + biotin) 
was at least 10-fold higher for free XPA treated with NHS-biotin than for XPA-ATR complex 
modified under identical conditions. Intensities of other biotinylated XPA peptide fragments in 
the absence and presence of ATR varied within ±20%. This Table was created by Steven M. 
Shell. 
 
 
Lys-188 and the XPA-ATR Interaction  
Figure 2-2A is a view of the minimum DNA-binding domain structure of XPA as 
determined by NMR spectroscopy (PBD code 1D4U) (134). ATR phosphorylates XPA at serine 
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196 (shown in green), which is located in the turn of a helix-turn-helix motif, a part of the 
proposed DNA-binding cleft. Protected lysine residue Lys-188 (shown in blue) is also located in 
the helix-turn-helix motif and is oriented in nearly the same plane as Ser-196. This is consistent 
with the fact that phosphorylation requires binding of ATR to XPA. 
Given that Lys-188 is shielded from the solvent in the presence of ATR (Table 2-1), site-
directed mutagenesis of Lys-188 was performed to investigate its possible role in XPA-ATR 
complex formation. Thus, pcDNA3.1 expression constructs were generated in which Lys-188 
was changed to either alanine (K188A) or glutamic acid (K188E), and the vectors were stably 
expressed in XPA
−/−
 cells. Coimmunoprecipitation assays were performed to examine the effects 
of the Lys-188 mutations on ATR binding to XPA. As shown in Figure 2-2B top, anti-XPA 
antibody efficiently co-immunoprecipitated ATR from whole cell lysates generated from XPA
−/−
 
cells complemented with wild-type XPA protein. Consistent with previous observations, UV-C 
irradiation increased the affinity of ATR for XPA but was unnecessary for the interaction (73). 
Interestingly, XPA-K188E protein co-immunoprecipitated with ATR in a similar pattern to that 
observed for the wild-type protein, although its affinity seemed slightly reduced (this work was 
done by Steven M. Shell). The K188A mutation, however, completely abolished the XPA-ATR 
interaction in both the irradiated and un-irradiated cells. These results were confirmed by the 
reversed coimmunoprecipitation in which XPA was coimmunoprecipitated by anti-ATR 
antibody (Figure 2-2B bottom). 
Effect of K188A Mutation on Nuclear Import of XPA upon UV Irradiation and DNA Damage 
Repair  
We previously reported that after DNA damage, XPA translocates from the cytoplasm to 
the nucleus in an ATR-dependent manner (74). Thus, an interesting question is whether the 
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ATR-XPA interaction is required for XPA nuclear import. To address this question, a cellular 
fractionation assay was performed using XPA
−/−
 cells expressing recombinant wild-type XPA 
(XPA-WT) or XPA-K188A mutant. After UV-C irradiation (20 J/m
2
), wild-type XPA is re-
distributed from the cytoplasm to the nucleus. However, UV-C irradiation does not affect the 
cellular distribution of the XPA-K188A protein (Figure 2-2C top). These results suggest that the 
K188A mutation negatively affects the ability of ATR to induce nuclear accumulation of XPA in 
response to DNA damage. The results were confirmed by an immunofluorescence microscopy 
assay in which the subcellular localization of XPA was directly visualized (Figure 2-2C bottom). 
Interestingly, the phosphorylation of XPA at Ser-196 appears to have no effect on XPA nuclear 
import. Collectively, these suggest that physical interaction between XPA and ATR, but not Ser-
196 phosphorylation, may play a role in DNA damage-induced XPA nuclear import. It should be 
noted that although the total levels of XPA appeared to be different in cells expressing XPA-WT 
and mutant, the effect of total XPA level on the UV-induced subcellular translocation patterns of 
XPA should be very minimal. To determine the dependence of NER on the Lys-188-mediated 
ATR-XPA interaction, XPA-WT or XPA-K188A mutant cells were cultured on glass coverslips 
and irradiated through isopore filters to generate localized DNA damage. Damage foci were 
visualized by immunofluorescence microscopy and measured as a function of repair time. As 
shown in Figure 2-2D, foci removal is impaired in XPA
−/−
 and XPA-K188A cells compared with 
XPA-WT cells, suggesting that the mutation largely abrogated the repair. 
41 
 
Figure 2-2. Residue Lys-188 is required for XPA-ATR complex formation, XPA nuclear import 
upon UV damage, and NER 
A, ribbon diagram of XPA minimum DNA-binding domain (PDB code 1D4U), indicating that 
the identified lysine residue Lys-188 (shown in blue) is located in the helix-turn-helix motif-
containing ATR phosphorylation site serine 196. B, point mutations were generated in the 
pcDNA-XPA expression construct generating alanine (K188A) and glutamic acid (K188E) 
substitutions. The mutated constructs as well as wild-type XPA were stably expressed in XPA
−/−
 
cells, and their effects on the XPA-ATR interaction were investigated by coimmunoprecipitation 
(IP). The K188A mutant protein was unable to coimmunoprecipitate ATR or vice versa from 
lysates generated from UV-irradiated or un-irradiated cells. The K188E mutant maintained the 
interaction between XPA and ATR and exhibited a similar UV-induced pattern as seen for XPA-
WT. The relative amounts of the co-immunoprecipitated ATR were estimated by its ratio to 
those of the immunoprecipitated protein that were normalized to the loading control IgG. Data in 
this panel was generated by Steven M. Shell. C, XPA cells complemented with wild-type XPA 
and XPA-K188A were subjected to subcellular fractionation and immunofluorescence 
42 
microscopy analysis. The specificity of the fractionation assay is demonstrated by the presence 
and absence of cytoplasm-specific and nucleus-specific proteins β-actin and PARP (poly(ADP-
ribose) polymerase), respectively, in the cytosol and nucleus. D, cells were irradiated with UV of 
50 J/m
2
 through isopore filters to induce localized DNA damage and then fixed at the indicated 
times for immunofluorescence analysis with anti-CPD antibody. Nuclei containing at least one 
defined CPD focus were counted as a percentage of total DAPI-stained nuclei and plotted versus 
time post-irradiation. At least 50 DAPI-stained nuclei were randomly chosen for the 
quantification at each time point. 
 
XPA Phosphorylation and DNA Damage Repair  
Another possible role of ATR binding to XPA in cells is to phosphorylate the NER 
protein. The ATR-dependent phosphorylation of XPA previously has been shown to play a role 
in cell survival after UV-C irradiation (73). Given the unique role of XPA in NER, we 
hypothesized that XPA phosphorylation may play a role in promoting removal of UV 
photoproducts. Previous experiments in which ATR kinase activity was inhibited by small 
interfering RNA knockdown reduced the repair rate of (6-4) photoproducts ((6-4)PPs) (74); 
however, most of the lesions were removed within several hours post-irradiation, which appears 
to be earlier than XPA phosphorylation (73). This suggests that the phosphorylation may not be 
involved in (6-4)PP repair. We, therefore, reason that XPA phosphorylation might play a role in 
promoting the removal of persistent lesions, such as CPDs. 
To test the notion, repair of UV-C-induced photoproducts was monitored by 
immunofluorescence microscopy in XPA
−/−
 cells complemented with either wild-type XPA or 
XPA in which serine 196 was replaced by alanine (S196A). As shown in Figure 2-3A, CPD and 
(6-4)PP foci (stained in red), formed in the nuclei of cells complemented with XPA-WT protein, 
decrease in size and frequency as the recovery time increases up to 24 h. However, CPD foci are 
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more persistent in nuclei from cells complemented with XPA-S916A. Nuclei from cells 
transfected with empty vector alone show little change in CPD focus size or frequency across 
time. These results suggest that CPD lesions are repaired at a slower rate in cells complemented 
with XPA-S196A compared with XPA-WT protein (Figure 2-3, A and B). In agreement with 
previous results, no substantial difference in repair rate was observed for (6-4)PPs between cells 
complemented with wild-type and phosphorylation-deficient XPA (Figure 2-3B). In a parallel 
DNA repair assay (Figure 2-3C), XPA-complemented cells were irradiated with UV-C (20 J/m
2
) 
followed by extraction of the genomic DNA. Equal amounts of purified DNA were then 
immobilized on nylon membrane and probed with antibody specific for CPDs. Consistently, 
CPD lesions were removed more efficiently in cells expressing XPA-WT compared with cells 
expressing phosphorylation-deficient XPA-S196A protein, whereas little repair occurred in XPA 
cells transfected with empty vector. These results suggest that XPA phosphorylation promotes 
the repair of persistent UV-induced photolesions. Also importantly, from the data generated by 
Moises A. Serrano, the phosphorylation is dependent on the ATR-XPA interaction as 
demonstrated in Figure 2-3D in which the XPA phosphorylation was abolished in cells 
expressing XPA-K188A mutant. Taken together, these results support the observation on the 
effects of XPA-K188A mutation on CPD repair in Figure 2-3D. 
To determine whether the reduced repair of CPD lesions by XPA-S196A was because of 
reduced nuclear translocation, we performed a cellular fractionation assay to determine the 
subcellular distribution of XPA-S196A in response to UV-C irradiation. As demonstrated in 
Figure 2-3E, phosphorylation-deficient XPA-S196A is imported into the nucleus with the same 
efficiency as wild-type XPA, suggesting that XPA translocation is not affected by the 
phosphorylation. The result is consistent with that determined by the immunofluorescence 
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analysis (Figure 2-3C). Taken together, XPA phosphorylation is likely involved in a mechanism 
independent of subcellular protein redistribution to promote repair of persistent DNA lesions. 
 
Figure 2-3. Effects of XPA phosphorylation on repair of cyclobutane pyrimidine dimers 
Recombinant pcDNA constructs containing wild-type XPA or XPA-S196A cDNA were stably 
expressed in XPA
−/−
 cells. A, cells were grown on coverslips and UV-irradiated at 20 J/m
2
 
through isopore filters to induce localized DNA damage followed by immunofluorescence 
staining with anti-(6-4)PPs and anti-CPD antibodies at the indicated time points. B, nuclei 
containing at least one DNA damage focus were counted as a percentage of total nuclei and 
plotted versus time post-irradiation. At least 50 DAPI-stained nuclei were randomly counted for 
each time point. C, genomic DNA was isolated from cells complemented with wild-type or 
phosphorylation-deficient XPA after UV-C irradiation. The DNA was immobilized on nylon 
membranes, and total CPDs were detected using mouse-anti-CPD. D, cells expressing 
recombinants XPA-WT and XPA-K188A, respectively, were UV-irradiated and then subjected 
to western blot analysis of phosphorylated and intact XPA. This data was generated by Moises 
A. Serrano. E, subcellular distribution of XPA-WT and XPA-S196A after UV-C irradiation was 
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determined by cellular fractionation. β-Actin and PARP (poly(ADP-ribose) polymerase), 
cytoplasm- and nucleus-specific proteins, respectively, demonstrate the specificity of the assay 
and serve as loading controls. 
 
Discussion 
Our previous work demonstrated that XPA is phosphorylated by the DNA damage 
checkpoint kinase ATR in response to UV irradiation at serine residue 196 located in the 
minimum DNA-binding domain of XPA (73). In addition, ATR directed the UV-induced 
subcellular redistribution of XPA from the cytosol to the nucleus in both a dose-dependent and 
time-dependent manner (74). Given the central role of XPA in nucleotide excision repair, an 
interaction between XPA and ATR may represent a novel regulatory mechanism for NER to be 
modulated by DNA damage checkpoints. The dependence of NER on ATR is further supported 
by a recent report by Auclair et al. (75). 
Our lab’s previous results (134) strongly imply a key role for the N-terminal α-helix of 
the XPA helix-turn-helix motif in the interaction with ATR and suggest that Lys-188 mediates 
the effects on this interaction indirectly by modulating the stability of the helix rather than 
through direct interaction with ATR. The significance of the ATR-XPA interaction has been 
shown by its requirement for XPA nuclear import in response to UV irradiation of the cells 
(Figure 2-3C). Because XPA is an indispensable factor for NER and the nuclear availability of 
XPA is critical for NER, it is reasonable to expect that NER may depend on ATR-XPA 
interaction. Indeed our result indicates that the nucleotide excision repair of UV-induced 
photolesions requires the ATR-XPA interaction in cells. There are at least two possible scenarios 
in which XPA nuclear translocation and, thus, NER could depend on ATR-XPA interaction. 
First, the interaction could occur in the nucleus, which reduces the nuclear concentration of free 
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XPA. The depletion of free XPA in the nucleus disrupts the concentration balance across the 
nuclear membrane and subsequently allows more XPA to be imported into the nucleus driven by 
favorable free energy. In the second scenario, XPA could form a complex with ATR in the 
cytoplasm and then be imported into the nucleus across the nuclear membrane in the complex 
form. 
It is obvious that ATR-XPA complex formation also is required for the phosphorylation 
of XPA. Phosphorylation of XPA at serine 196 has been previously shown to moderately 
promote cell survival after UV-C irradiation (73). Given that the only known function for XPA is 
in NER, we assayed UV-C-induced photoproducts removal to investigate the role of XPA 
phosphorylation in NER. We found that XPA
−/−
 cells complemented with XPA-S196A displayed 
a slower repair rate for CPD photoproducts when compared with wild-type XPA. By contrast, no 
effect has been observed for repair of (6-4) photoproducts. It has been well established that CPD 
is much more persistent DNA damage than (6-4) photoproducts (151). Taken together, these 
results suggest that XPA phosphorylation may play a role in stimulating NER activity for 
removal of persistent DNA damage through an as yet undetermined mechanism. This also 
appears consistent with our previous observation that phosphorylated XPA represents only a 
small portion of the cellular pool of XPA (73). We hypothesized that phosphorylation of XPA 
may modulate NER activity by altering the affinity of XPA for the damage site. Indeed, 
phosphorylated XPA was shown to associate more tightly with UV-damaged chromatin in cells 
than the wild-type XPA (73).  
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Abstract 
Cell cycle checkpoints play an important role in regulation of DNA repair pathways. 
However, how the regulation occurs throughout the cell cycle remains largely unknown. Here we 
demonstrate that nucleotide excision repair (NER) is regulated by the ATR/p53 checkpoint via 
modulation of XPA nuclear import and that this regulation occurs in a cell cycle-dependent 
manner. We show that depletion of p53 abrogated the UV-induced nuclear translocation of XPA, 
while silencing of Chk1 or MAPKAP Kinase-2 (MK2) had no effect. Inhibition of p53 
transcriptional activities and silencing of p53-Ser15 phosphorylation also reduced the damage-
induced XPA nuclear import. Furthermore, in G1-phase cells the majority of XPA remained in 
the cytoplasm even after UV treatment. By contrast, while most of the XPA in S-phase cells was 
initially located in the cytoplasm before DNA damage, UV irradiation stimulated bulk import of 
XPA into the nucleus.  Interestingly, the majority of XPA molecules were always located in the 
nucleus in G2-phase cells no matter whether the DNA was damaged or not. Consistently, the 
UV-induced Ser15 phosphorylation of p53 occurred mainly in S-phase cells, and the cyclobutane 
pyrimidine dimers (CPDs) were removed much more efficiently in S-phase cells than in G1-
phase cells. Our results suggest that upon DNA damage in S phase, NER could be regulated by 
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the ATR/p53-dependent checkpoint via modulation of the XPA nuclear import process. In 
contrast, the nuclear import of XPA in G1 or G2 phase appears to be largely independent of DNA 
damage and p53. 
 
Introduction 
The human genome is under constant threat of damage from exogenous genotoxic 
pollutants and carcinogens. Removal of DNA damage requires the dual action and coordination 
of cell cycle checkpoints and DNA repair machineries in each phase of the cell cycle (14). The 
nucleotide excision repair (NER) pathway is the primary mechanism in cells for the removal of 
helix-distorting, replication-blocking DNA adducts induced by exogenous agents such as UV 
radiation and a variety of genotoxic chemicals (7).  In humans, defects of NER lead to the 
clinical disorder Xeroderma pigmentosum (XP) which is characterized by an increased 
sensitivity to UV radiation and a predisposition to the development of skin cancers (38, 40). It 
remains elusive how NER is regulated by DNA damage checkpoints throughout the cell cycle.  
        The xeroderma pigmentosum group A protein (XPA) is one of eight factors that were found 
to be deficient in XP disorders (121), and the XPA-deficient cells exhibit the highest UV 
sensitivity among the XP cells (122). XPA is an indispensable factor for both the transcription-
coupled NER (TC-NER) and global genome NER (GG-NER) (76, 77). NER can be regulated by 
transcriptional and posttranscriptional control of the XPA protein (73, 74, 78-80, 123). 
Functionally, XPA is believed to play roles in verifying DNA damage, stabilizing repair 
intermediates, and recruiting other NER factors to the damage site (76, 124-130).  
        The DNA damage checkpoints survey the structural integrity of genomic DNA and 
coordinate multiple cellular pathways to ensure timely and efficient removal of DNA damage. 
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The ATM (ataxia telangiectasia mutated)- and ATR (ATM- and RAD3-related)-mediated 
checkpoint pathways are two major genome surveillance systems in human cells. Both ATM and 
ATR are protein kinases belonging to the phosphoinositide 3-kinase-like kinase (PIKK) family. 
These pathways are comprised of a series of DNA damage sensors, signal mediators and 
transducers, and downstream effectors (7, 13, 14, 103). Checkpoint kinase-1 (Chk1), p53, and 
MAPKAP Kinase-2 (MK2) are the three main downstream checkpoint proteins that can be 
directly or indirectly activated by ATR following UV irradiation (19, 152, 153). 
        ATR can be activated by genotoxic agents that cause replication stress associated with 
accumulated RPA (Replication Protein A)-coated ssDNA (154). In our previous studies, ATR 
and its kinase activity were found to be required for modulating XPA translocation into the 
nucleus from the cytosol upon UV-DNA damage (74). Consistently, ATR was reported to be 
required for maintaining NER activity primarily during S phase in human cells (75). When the 
XPA translocation is inhibited by disruption of the ATR-XPA interaction in the nucleus, DNA 
repair efficiency is significantly reduced (134). Regulation of nuclear import is necessary for 
timely localization of the repair proteins that participate in DNA repair (136). These findings 
lead us to propose that ATR regulation of the XPA nuclear import may directly coordinate the 
ATR checkpoint activity with NER. However, the question as to whether the ATR-regulated 
nuclear import of XPA upon DNA damage is cell cycle specific remains to be addressed. 
        In the current work, we demonstrate that UV-induced XPA nuclear import is cell cycle 
dependent and happens primarily in the S-phase, which may contribute to the ATR-regulated 
NER process. We also identified p53 as the ATR-regulated downstream protein required for the 
UV-induced XPA nuclear import and the removal of UV-DNA damage. 
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Materials and Methods 
Tissue Culture, Drugs, and Antibodies 
The A549/LXSN (p53+) and A549/E6 (p53-) cells were gifts from Dr. Jeffrey L. 
Schwartz (155). Cells were maintained in D-MEM supplemented with 10% FBS and 1% 
penicillin-streptomycin.  All cell lines were grown at 37°C, 5% CO2. UV-C irradiation was 
performed using a 254 nm lamp at a flounce of 0.83 J/m
2
/sec. For time course analysis, cells 
were incubated at 37°C, 5% CO2 for the indicated amounts of time. For inhibition of p53 
transcriptional activities, pifithrin-α (Sigma Chemical Co.) was added into the culture medium at 
30 µM and the cells incubated for 20 hours. For western blotting and immunofluorescence 
staining of XPA, primary mouse polyclonal antibody against XPA was purchased from Kamiya 
Biomedical Company. For western blotting, mouse monoclonal antibody against PARP, rabbit 
polyclonal antibody against p53, mouse monoclonal antibody against Chk1, and goat anti-MK2 
antibody were purchased from Santa Cruz Biotechnology Co.  A FITC conjugated primary 
mouse anti-actin antibody was obtained from Sigma Chemical Co. The anti-actin and anti-PARP 
antibodies were used in western blots to confirm successful subcellular fractionations and protein 
loadings. 
RNAi and Transfections 
p53 and XPA siRNA duplexes were purchased from Santa Cruz. MK2 siRNA and Chk1 
siRNA duplexes were synthesized by Genepharm using the following sequences: MK2 siRNA, 
sense strand 5′-UGACCAUCACCGAGUUUAUdTdT-3′ and antisense strand 5′-
AUAAACUCGGUGAUGGUCAdTdT-3′; Chk1 siRNA, sense strand 5′-
ACAGUAUUUCGGUAUAAUATT-3′ and antisense strand 5′-
UAUUAUACCGAAAUACUGUTG-3′. The siRNA transfection reagent was purchased from 
54 
Polyplus-transfection and the transfections were done by following their instructions. Briefly, 
cells were grown to 30-40% confluence and washed with FBS- and antibiotic-free medium. 
siRNA duplexes were added to a small volume of FBS- and antibiotic-free medium and 
incubated with transfection reagent for 10 min. This siRNA/reagent mixture then was added to 
cells in FBS- and antibiotic-free medium at a final siRNA concentration of 5-10 nM. After 5-7 
hours incubation, concentrated FBS and antibiotic medium were added into the transfection 
medium for further incubation. The cells were UV-irradiated at either 48 or 72 hrs of post-
transfection. For time course experiments, siRNA-containing medium was taken off the cells for 
UV irradiation and added back for further cell growth. The p53 3’-UTR siRNA duplexes were 
purchased from QIAGEN Incorporation. Plasmids of human wild-type p53 and the Ser15Ala p53 
mutant were gifts from Dr. Karen Vousden at the Beatson Institute for Cancer Research, United 
Kingdom. The co-transfection of p53 3’-UTR siRNA with p53 plasmids were done using 
Lipofectamine™ 2000 (Invitrogen) by following the company’s instructions. 
Immunoblotting 
Cells were harvested by scraping or trypsin digestion, and re-suspended in lysis buffer 
(50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1x protease inhibitor 
cocktail [Roche]). 2X SDS loading buffer was added to the lysates and the mixtures were heated 
at 90°C for 10 min to denature proteins. After running the samples in SDS-PAGE, proteins in the 
gel were transferred onto PVDF membrane. The membranes then were blocked with 5% nonfat 
milk in TBST and probed with specific primary and secondary antibodies. Chemiluminescence 
signal was captured with a FUJI Film camera, and western blot images were processed with 
Multi-Gauge 3.0 software. 
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Cell Synchronization, Flow Cytometry, and BrdU Incorporation Assay 
Cells were synchronized by mitotic “shake off” as described previously (156). A549 cells 
were synchronized by seeding cells into four 300 cm
2
 flasks and grown to ~70 % confluence. 
Mitotic cells were collected by physically shaking the flasks to dislodge the loosely attached 
cells with monitoring by phase contrast microscopy at 100X magnification. For synchronizing 
HeLa cells, the cells were cultured in four 300 cm
2
 flasks and treated with nocodazole at 100 
ng/ml for 8 hours (to enrich the mitotic cells) before shaking off. Collected mitotic cells then 
were seeded into 12-well or 6-well plates at 30-40% confluence and left to grow in standard 
culture condition. The synchronization was confirmed using BrdU labeling at each 4-hr time 
point after “shake off” and by flow cytometric cell cycle analysis after propidium iodide staining 
of the nuclear DNA. 
For propidium iodide staining, cells were fixed in cold 70 % ethanol for 1- to 16-hrs at 
4°C. Fixed cells were centrifuged at 10,000xg for 10 sec to pellet the cells, and propidium iodide 
solution (PBS with 20 ug/mL propidium iodide and 100 ug/mL RNase (Invitrogen)) was added 
to re-suspend the cell pellet. The resuspended cells were incubated for another 30 min at 37°C. 
Stained cells then were analyzed using an Accuri C6 flow cytometer or a BD Biosciences flow 
cytometer to assess the DNA content.  The cell synchronization results were processed by FCS 
software. 
BrdU incorporation was performed following the company’s instructions (Cellomics) 
with a few modifications. Briefly, cells were grown on coverslips and labeled with BrdU by 
adding the nucleoside to a final concentration of 160 μM; the cells were grown for an additional 
15 min to label those in S phase. Cells then were fixed with 4% paraformaldehyde solution 
before treatment with permeabilization buffer. After blocking with 15% BSA for 1hr at room 
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temperature, primary mouse anti-BrdU antibody and fluorescence-conjugated secondary 
antibodies (Invitrogen) were used to detect BrdU incorporation. Stained cells were visualized 
using 20X magnification with fluorescence microscopy. 
Subcellular Fractionation 
Subcellular fractionation was performed using the Proteo JET
TM
 cytoplasmic and nuclear 
protein extraction kit (Fermentas) by following the procedures suggested by the manufacturer. 
Briefly, 10 volumes of cell lysis buffer (with 1x protease inhibitors) were added to 1 volume of 
packed cells. After a short vortexing and incubation on ice for 10 min, cytoplasm was separated 
from nuclei by centrifugation at 500xg for 7 min at 4ºC. Isolated nuclei were washed once or 
twice with 500 μL of the nuclei washing buffer and then collected by centrifugation. The 
collected nuclear pellets were re-suspended in ice-cold nuclear storage buffer, and 1/10 volume 
of the nuclear lysis reagents was added to the mixtures to lyse the nuclei with rotation for 15 min 
at 4⁰C. Nuclear lysate was collected by centrifugation at 20,000xg for 15 min at 4ºC. In all of the 
fractionation experiments, western blotting of β-actin and PARP were assessed to check 
cytoplasmic and nuclear protein loading, respectively.  
Immunofluorescence Microscopy 
For immunofluorescence microscopy of proteins, cells were grown on coverslips before 
the initiation of experimental treatments. After UV-C irradiation and specified recovery times, 
the cells were fixed with 100% cold methanol and blocked with 15% BSA for 1hr at room 
temperature. Proteins were detected with primary antibodies and fluorescence-conjugated 
secondary antibodies (Invitrogen). Cells on coverslips were coated with prolong gold antifade 
reagent containing DAPI (Invitrogen) before microscopic examination using 100X 
magnification. 
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Slot-blot DNA Repair Assay 
Cells were seeded at 1x10
6
 cells per 10 cm tissue culture dish and allowed to grow 
indicated times prior to UV-C irradiation. After irradiation, cells were allowed to recover for the 
indicated periods, followed by genomic DNA purification using the QIAGEN DNA Mini Kit. 
The purified DNA was quantified by measuring the light absorbance at 260 nm and diluted to 0.2 
μg/mL in a final volume of 200 uL TE buffer (10 mM Tris-Cl, pH 7.5. 1 mM EDTA). The DNA 
was denatured by incubating at 90 
°
C for 10 minutes, followed by rapid chilling on ice water 
before adding an equal volume of 2 M ammonium acetate. Samples were immobilized on a 
nylon membrane and probed using monoclonal mouse anti-CPD or anti-(6-4)PP antibodies 
(Kamiya Biomedical Co.).   
Statistical Analysis 
The statistical analysis of samples was performed with a two-tailed student’s t-Test, and a 
p-value of less than 0.05 was considered as significant. 
 
Results 
UV-induced XPA Nuclear Import Depends on p53  
We previously demonstrated that UV-induced XPA nuclear translocation is dependent on ATR 
(74). Since p53 is a major downstream substrate of ATR, it is of interest to determine if p53 is 
required for XPA nuclear import. Thus, cells were transfected with p53 siRNAs. As shown in 
Figure 3-1A, the p53 silencing inhibited the UV-induced nuclear import of XPA. In the control 
siRNA-transfected cells, most of XPA molecules were imported into the nucleus after DNA 
damage (compare the nuclear XPA-to-cytoplasmic XPA (nXPA/cXPA) ratio in lanes 6 and 2 
with the ratio in lanes 5 and 1; also see the adjacent plot). By contrast, the nuclear 
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XPA/cytoplasmic XPA ratio was significantly reduced in the cells with p53 depletion (Figure 3-
1A). β-actin and PARP are cytoplasmic and nuclear proteins, respectively, and were probed as 
controls to indicate the quality of the cytoplasmic/nuclear protein fractionation. An 
immunofluorescence microscopy assay also was performed and the same effect of p53 on the 
XPA nuclear import in the cells was observed (Figure 3-1B). In the absence of DNA damage, 
most XPA molecules were located in the cytosol of the cells transfected with control siRNA, but 
were translocated into the nucleus following UV irradiation. However, only a small portion of 
cytosolic XPA was translocated into the nucleus in the p53-silenced cells even after UV 
irradiation. To further confirm these results, A549/E6 (p53-) and A549/LXSN (p53+) cells were 
employed. In A549/E6 (p53-) cells, p53 is abrogated due to overexpression of human 
papillomavirus
 
type 16 E6 protein (155), while in A549/LXSN (p53+) cells wild-type p53 is 
expressed. As shown in Figure 3-1C, the UV-induced XPA nuclear translocation was disrupted 
in the p53-deficient cells as compared to the p53-proficient cells. 
 
Figure 3-1. p53 is required for the XPA nuclear import upon UV irradiation 
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A, p53 was transiently knockdown with siRNA duplexes in HeLa cells. After treatment with or 
without 20 J/m
2
 UV followed by a 2-hr recovery, subcellular fractionation and western blotting 
were performed to assess the re-distribution of XPA. β-actin and PARP were probed as 
cytoplasmic and nuclear protein controls, respectively. The quantitative data were obtained from 
at least three independent experiments. nXPA/cXPA represents the ratio of nuclear XPA to 
cytoplasmic XPA. B, Immunofluorescence microscopy analysis of cells transfected with control 
or p53 siRNA and with or without UV irradiation. C, A549/LXSN (p53+) and A549/E6(p53-) 
cells were mock- or UV-irradiated. Cytosol and nuclear fractions were collected and analyzed by 
western blotting. D, A459 cells were treated with pifithrin-α (30 uM), an inhibitor of p53 
transcriptional activity, for 20 hrs. After irradiation with UV followed by a 2-hr recovery, the 
cells were analyzed for subcellular localization of XPA. The * in the quantification plots 
indicates a statistically significant (p < 0.05) difference between the groups being compared. 
 
We next examined the effect of transcriptional function of p53 on XPA nuclear import. 
A549 cells were pre-incubated with pifithrin-α, a p53 transcriptional activation inhibitor, before 
the UV treatment. As shown in Figure 3-1D, the presence of pifithrin-α significantly reduced the 
UV-induced XPA nuclear import (the nXPA/cXPA ratio) as compared to the DMSO-treated 
cells. These data suggest that p53 may regulate the UV-induced nuclear import of XPA through 
its transcriptional activity. 
Neither Chk1 nor MK2 is Required for UV-Induced XPA Nuclear Import 
Chk1 is a close downstream kinase substrate of ATR and may play an important role in 
transducing damage signal in the ATR pathway by phosphorylating p53. MAP kinase-activated 
protein kinase 2 (MAPKAPK2 or MK2) is another downstream kinase of ATR recently was 
identified as an alternative checkpoint in p53-deficient cancer cells (19). It is of interest to 
investigate whether Chk1 and/or MK2 are involved in the UV-induced nuclear translocation of 
XPA. To this end, A549 cells were transfected with Chk1 or MK2 siRNA followed by 
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subcellular fractionation. The results in Figures 3-2A and 3-2B indicate that neither Chk1 nor 
MK2 is required for the UV-induced XPA nuclear import as no difference of the import was 
observed between the control siRNA- and the Chk1 or MK2 siRNA-transfected cells. Similar 
results also were obtained for cells depleted of both Chk1 and MK2
 
(Figure 3-2C). By contrast, 
siRNA knockdown of ATR in the A549 cells did significantly reduce the UV-induced nuclear 
import of XPA (Figure 3-2C), confirming the involvement of ATR/p53 checkpoint pathway in 
the regulation of XPA nuclear import. 
 
Figure 3-2. Cell cycle checkpoint proteins Chk1 and MK2 are not required in the UV-induced 
nuclear import of XPA 
A, siRNA duplexes targeting Chk1 were transiently transfected into A549 cells followed by 
mock or 20 J/m
2
 UV irradiation and a 2-hr recovery. The localization of XPA was assessed using 
subcellular fractionation followed by western blot analysis. PARP and β-actin proteins were 
probed as nuclear and cytoplasmic protein controls, respectively. B, A549 cells were treated with 
MK2 or control siRNA, followed by UV irradiation. After a 2-hr recovery period, irradiated cells 
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were fractioned and analyzed by western blotting. C, Chk1 and MK2 were either simultaneously 
knocked down by Chk1 and MK2 siRNAs, or knocked down by ATR siRNA. A549 cells were 
transfected by siRNAs either for simultaneous knockdown of Chk1 and MK2, or for ATR. Then 
the UV-induced XPA nuclear import in these cells was assessed by fractionation and western 
blotting. 
UV-damage Induced XPA Nuclear Import Occurs Primarily in S phase  
Next we addressed the question of whether the ATR-dependent XPA nuclear import 
following DNA damage is cell cycle specific as is the ATR checkpoint (157). To avoid any 
physiological perturbation associated with drug treatments, A549 cells were synchronized by 
mitotic “shake off” as described previously (156). The collected mitotic cells were seeded into 
cell culture dishes and maintained at standard culture condition to generate a synchronized cell 
population for subsequent analysis. The synchronization efficiency was assessed by propidium 
iodide (PI) staining followed by flow cytometric analysis and by assessing the cells positively 
labeled with BrdU under fluorescence microscopy (Figure 3-3A). Based on the results (data 
generated by Zhiping Dong), the 4-hour post-“shake off” time point was selected as the G1 cell 
population (most cells with a 2C DNA content and the lowest level of BrdU labeling); the 14-
hour time point was selected as the S-phase cell population (DNA content between 2C and 4C 
and highest BrdU labeling); the 18-hour post- “shake off” time point was selected as the G2 cell 
population (4C DNA content and low BrdU labeling). The location of XPA molecules in the 
synchronized cell populations was assessed using immunofluorescence. Figure 3-3B shows that 
in the G1 cells most of the XPA molecules were located in the cytosol, while there was only a 
slight accumulation of XPA in the nucleus after UV irradiation. By contrast, although most of 
the XPA molecules were located in the cytosol in S phase before UV irradiation, they were 
imported into the nucleus after UV treatment. Interestingly, in the G2 cell population most cells 
showed significant levels of XPA in the nucleus either with or without UV irradiation.  
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Figure 3-3. DNA damage-induced XPA nuclear accumulation occurs primarily in S phase 
A, Mitotically-synchronized A549 cells grown for the indicated time periods were stained with 
propidium iodide for analysis of the cell cycle distribution (Panel A, left) or labeled with BrdU to 
identify synchronized S-phase cells (panel A, right). B, Immunofluorescence microscopic 
analysis of the subcellular localization of XPA in the synchronized cells. Synchronized A549 
cells were mock- or UV-treated (20 J/m
2
) and left to recover for 2 hrs. Cells were fixed and 
stained with primary and fluorescence--conjugated secondary antibody to determine the 
localization of XPA. At least 100 cells were examined, and the representative data is shown. C, 
Left: Mitotically-synchronized HeLa cells were stained with propidium iodide followed by flow 
cytometry analysis. Right: Subcellular fractionation followed by western blotting was performed 
to analyze the subcellular localization of XPA in each phase of the cell cycle after UV irradiation 
of the synchronized HeLa cells. PARP and β-actin were probed as nuclear and cytoplasmic 
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protein loading controls, respectively. At least three independent experiments were performed 
and representative data is presented.  
 
To determine whether this cell phase-specific translocation of XPA is a general response, 
synchronized HeLa cells (Figure 3-3C, left) were treated with or without UV and then subjected 
to subcellular fractionation for analysis of subcellular localization of XPA in each phase of cell 
cycle. Consistent with the observation in the A549 cells, we found that in HeLa cells, the UV-
induced XPA nuclear translocation also occurs primarily in the S phase (20 hrs post- “shake 
off”) (Figure 3-3C, right). Similarly, in the G1 phase cells (6 hrs post- “shake off”), most XPA 
remained in the cytoplasm even after UV treatment, while in the G2 phase cells (28 hrs post- 
“shake off” time point), a large amount of XPA was found in the nucleus even without UV 
irradiation. 
Repair of CPDs is Significantly Slower in G1 than in S phase 
As described above, the UV-induced XPA import occurs primarily in S-phase cells, 
particularly in comparison with that in G1 phase (Most of the XPA is located in the nucleus in 
G2 phase even in the absence of DNA damage). Thus, it was expected that repair of the UV-
induced DNA damage could be more efficient in S phase cells than in G1 phase cells. To 
confirm this, HeLa cells were mitotically synchronized and the cells in either G1 or S phase were 
UV-irradiated at a dose of 10 J/m
2
, followed by indicated periods of recovery (Figure 3-4A). As 
shown in Figure 3-4B, more CPDs were generated in S phase than G1 phase cells following UV 
irradiation, likely due to the more open chromatin structures in S phase than in G1 phase (thus 
less protection of DNA from UV damage). As expected, the repair rate of CPDs was much 
higher in S phase than in G1 phase cells.  In contrast, no difference in repair efficiency for 6-
4PPs was observed between G1 and S phase cells (Figure 3-4B). It is well known that 6-4PPs 
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can be removed in cells within a few hours while CPDs are the much persistent DNA damage 
that is responsible for the UV-induced cell death in NER-proficient cells (158). It also is known 
that 6-4PPs are the minor lesions induced by UV in cells as compared with CPDs (159, 160). 
Since the repair of 6-4PPs is generally so efficient, it is possible that the relatively low level of 
XPA in the nuclei of G1 phase cells is adequate for efficient removal of the relatively small 
quantity of 6-4PPs.  
 
                         C 
 
Figure 3-4. Removal of UV-induced DNA damage in G1- and S-phase cells 
A, Mitotically-synchronized HeLa cells were fixed and stained with propidium iodide at 
indicated time points following the mitotic “shake off”. The cell cycle distribution then was 
analyzed by flow cytometry. Cells at G1 (at the 6 hours post-“shake off”) or S phases (20 hours 
post-“shake off”), were UV irradiated at 10 J/m2, followed by a recovery of 24 hours. B, Cells at 
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G1 or S phases were UV irradiated at 10 J/m
2
, followed by the indicated periods of repair. 
Removal of CPDs and 6-4PPs was measured by slot-blot assay. The amounts of CPDs or 6-4PPs 
were normalized to the values at zero hour and quantified based on three independent 
measurements. C, An evaluation of the slot-blot DNA repair assay. HeLa cells were treated with 
different does of UV-C and harvested immediately. The amount of CPDs on the blot were 
detected (left) and subjected to linear regression analysis (right). It shows that the detection of 
CPDs in our assay (panel B) is in a linear range within a 95% confidence. 
 
Phosphorylation of p53 on Serine15 is Involved in the UV-induced XPA Nuclear Import 
Although our results showed that p53 is required for the XPA nuclear import (Figure 3-
1), it is unclear whether the requirement involves the checkpoint activity of p53. Therefore, we 
examined the effect of the phosphorylation of p53 at Ser15 on XPA nuclear import. The p53 
phosphorylation at Ser15 plays an important role in ATR-dependent checkpoint signaling (7, 
152). Consistent with the observed cell phase-specific nuclear import of XPA induced by UV, 
the UV-induced phosphorylation of p53 on Ser15 was found to occur predominantly in the S-
phase cell population (Figure 3-5A). We next assessed the requirement of p53 serine15 for the 
UV-induced XPA nuclear import. For this purpose, the endogenous p53 in A549 cells was 
depleted using 3’UTR siRNA while the cells transiently expressed recombinant siRNA-resistant 
wild-type p53 or S15A-mutant p53. The deficiency of the Ser15 phosphorylation in the p53-
S15A construct-transfected cells was confirmed by western blotting (Figure 3-5B). Also shown 
in Figure 3-5B, the UV-induced XPA nuclear import in the cells expressing p53-S15A was 
significantly lower than in the cells expressing wild-type p53. 
66 
 
 
 
 
 
Figure 3-5. Phosphorylation of p53 is involved in the UV-induced XPA nuclear import 
A, Mitotically synchronized A549 cells were mock-treated or irradiated with 20 J/m
2
 of UV-C, 
and allowed a 2-hr recovery before accessing the phosphorylation of p53 at Ser15 by western 
blotting. B, Constructs for expressing human wild-type p53 or the S15A mutant of p53 were co-
transfected with p53 3’-UTR siRNA into A549 cells. 72 hours after transfection, the A549 cells 
were mock- or UV (20 J/m
2
)-treated and allowed a 2-hr recovery. The UV-induced 
phosphorylation of p53 and the XPA in nuclear fractions were then analyzed by western blotting. 
The right panel shows the efficiency of siRNA knockdown of endogenous p53 and the level of 
recombinant p53 in the cells co-transfected with p53 3’-UTR siRNA and wild-type p53 
construct. 
 
Discussion 
A precise regulation of DNA repair is essential for cells to function normally in response 
to DNA damage. Given the key role of XPA in NER, results from our previous (74, 134) and 
current studies suggest that the ATR-dependent regulation of the damage-induced XPA nuclear 
import may represent a novel mechanism by which NER activity can be regulated by DNA 
damage checkpoints. Here we found that this regulation occurs primarily in S-phase, which well 
reflects the fact that DNA is most vulnerable to insult in S phase in terms of maintaining genome 
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integrity. This is also consistent with the recent report that ATR kinase is required for GG-NER 
exclusively during S phase (75). 
We also examined whether any of the major downstream checkpoint substrates of ATR 
such as p53, Chk1 or MK2, is involved in the regulation of the UV-induced XPA nuclear import. 
Our results indicate that the XPA nuclear import is dependent on p53 in cells responding to UV 
damage (Figure 3-1), but neither Chk1 nor MK2 are required for this XPA nuclear translocation 
(Figure 3-2). The results suggest a regulatory role of p53 in NER, which is in agreement with 
previous studies (161-166). We found that not only is the p53 protein itself necessary (as shown 
in the siRNA knockdown experiments), but also the transcriptional function of p53 and the 
damage signaling via p53-ser15 phosphorylation are required for the UV-induced XPA nuclear 
import (Figures 3-1 and 3-5). In fact, the Ser15 phosphorylation of p53 has been shown to 
stimulate the transcriptional functions of p53 through its increased association with p300 co-
activator (167-169)  and stabilization via disruption of binding to MDM2 (170). Thus, the effect 
of p53-ser15 phosphorylation appears to converge with that of the p53 transcription activation 
inhibitor pifithrin-α. The Ser15 of p53 can be phosphorylated either directly by ATR or by ATR-
activated Chk1 in response to UV irradiation (4, 7, 152, 153). Since Chk1 was not required for 
UV-induced XPA nuclear import (Figure 3-2), our results suggest that ATR kinase may directly 
phosphorylate p53 for transcriptional activation of the XPA nuclear translocation. Given that p53 
activates transcription of multiple genes involved in numerous cellular processes (47), it is 
possible that p53 may enhance the transcription of the genes involved in XPA trafficking from 
cytoplasm to nucleus (171-173). More recently, studies have showed that the transcription factor 
E2F1 plays a role in facilitating the recruitment of XPA and other NER factors to the UV-
induced DNA damage sites and this appears to be mediated by ATM- and ATR-dependent 
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phosphorylation of E2F1 at Ser31 (174, 175). Evidently, future investigation is needed to 
identify the p53-regulated transcriptional targets that are involved in protein nuclear import 
process. 
In contrast to the case in S phase, most of the XPA molecules remained in the cytoplasm 
of G1-phase cells after UV irradiation, while XPA normally accumulated in the nucleus in G2-
phase cells even without DNA damage. In addition, the level of UV-induced Ser15-
phosphorylation of p53 was much lower in G1- and G2-phase cells than in S-phase cells (Figure 
3-5A). These results suggest that the UV-induced XPA nuclear import happens predominately in 
S phase, while the XPA nuclear import in G1 and G2 phases is largely, if not fully, independent 
of UV irradiation and p53. Consistently, DNA repair of UV-induced CPDs was much more 
efficient in S phase than in G1 phase (Figure 3-4). Also interestingly, it was previously 
demonstrated that p53 deficiency had a negative impact on GG-NER but not on TC-NER (165, 
166). Given the indispensable role of XPA in both GG-NER and TC-NER, the observation of a 
p53 requirement for the UV-induced XPA nuclear import in S-phase cells implies that the TC-
NER may predominately occur in other cell cycle phases in a p53-independent manner. 
Consistently, the rate of transcription is generally low during S phase except the transcription for 
histone production.  
        Compared to the UV-induced XPA nuclear translocation in S phase, the subcellular 
distributions of XPA in the absence and presence of UV are very different in G1 and G2 phases. 
For G1 phase in typical human cells, it lasts much longer than S phase and the G1-phase cells do 
not experience a replication pressure requiring a fast repair of DNA damage. Thus, it is possible 
that the relatively lower rate of NER could be sufficient for timely removal of DNA damage by 
the end of G1 phase. In addition, the G1/S DNA damage checkpoint could also prevent the cells 
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from entering S phase before the damage has been removed. In the case of G2 phase, since XPA 
nuclear accumulation occurs even in the absence of DNA damage, the accumulation is not a 
residual effect of an S phase accumulation.  This may imply a quick removal of DNA damage in 
G2. It may also implicate a possible role of XPA in G2 maintenance or G2/M checkpoint 
regulation in normal cell cycle. Indeed, depletion of XPA protein in cells changed the population 
distribution of cells in the cell cycles (data not shown).  Although the potential role of XPA in 
normal cell cycle is of interest, it is out of scope of this study and deserves further investigations. 
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UV-INDUCED NUCLEAR IMPORT OF XPA IS MEDIATED BY IMPORTIN-Α4 IN AN 
ATR-DEPENDENT MANNER (139) 
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Abstract 
Xeroderma pigmentosum Group A (XPA) is a crucial factor in mammalian nucleotide 
excision repair (NER) and nuclear import of XPA from the cytoplasm for NER is regulated in 
cellular DNA damage responses. In this study, experiments were carried out to determine the 
transport mechanisms that are responsible for the UV-induced nuclear import of XPA. Using 
subcellular fractionation, RNAi and immunofluorescence microscopy assays, we found that, in 
addition to the nuclear localization signal (NLS) of XPA, importin-α4 and/or importin-α7 are 
required for the XPA nuclear import. Further investigation indicated that importin-α4 and 
importin-α7 directly interacted with XPA in cells. Interestingly, the binding of importin-α4 to 
XPA was dependent on UV-irradiation, while the binding of importin-α7 was not, suggesting a 
role for importin-α7 in nuclear translocation of XPA in the absence of DNA damage, perhaps 
with specificity to certain cell-cycle phase. Consistent with the previous report of a dependence 
of UV-induced XPA nuclear import on ataxia telangiectasia and Rad3-related protein (ATR) 
knockdown of ATR reduced the amount of XPA interacting with importin-α4. In contrast, the 
GTPase XPA binding protein 1 (XAB1), previously proposed to be required for XPA nuclear 
import, showed no effect on the nuclear import of XPA in our siRNA knockdown analysis. In 
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conclusion, our results suggest that upon DNA damage transport adaptor importin-α4 imports 
XPA into the nucleus in an ATR-dependent manner, while XAB1 has no role in this process. In 
addition, these findings reveal a potential new therapeutic target for the sensitization of cancer 
cells to chemotherapy. 
 
Introduction 
Human genomic DNA is constantly exposed to endogenous and exogenous damaging 
reagents, which may lead to genome instability. Removal of these structural and chemical 
abnormalities in the DNA requires timely and coordinate recruitment of DNA repair factors to 
the damaged DNA (7, 14). The NER pathway is the primary mechanism in cells for the removal 
of helix-distorting, replication-blocking bulky DNA adducts that are induced by exogenous 
agents such as UV radiation and a variety of genotoxic chemicals (7, 14). In humans, defects in 
nucleotide excision repair (NER) lead to the clinical disorder xeroderma pigmentosum (XP) 
which is characterized by an increased sensitivity to UV radiation and a predisposition to the 
development of skin cancers (40, 177). The XPA protein is one of eight factors that were found 
to be deficient in XP disorders (121), and the XPA-deficient cells exhibit the highest UV 
sensitivity among the XP cells (122). XPA is an indispensable factor both for transcription-
coupled NER and global genome NER (76, 77). Functionally, XPA is believed to play roles in 
verifying DNA damage, stabilizing repair intermediates, and recruiting other NER factors to the 
damaged DNA (7, 51, 124, 127, 128, 130, 146, 178-182). Because of XPA’s crucial functions in 
NER, the activity of NER and sensitization of cancer cells to chemotherapy can be regulated by 
transcriptional and posttranscriptional control of the XPA protein (73, 74, 78-80, 123). In 
addition, recent studies demonstrated that besides its anticipated functions in NER, XPA also 
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may participate in other cellular events in the absence of genotoxic insults, such as facilitating 
chromatin modification for transcription (183), inhibiting DNA double-strand break repair in 
progeria (149), and potential involvement in DNA replication (173). 
Given the important nuclear functions of XPA in NER (7, 136), it is of interest to study 
the DNA damage-dependent nuclear import of XPA (74, 135, 138), and also targeting protein 
trafficking could be a strategy to improve the sensitivity of cancer cells to chemotherapy agents 
(137). It was previously shown that the DNA damage-induced nuclear import of cytoplasmic 
XPA for NER in S phase is a DNA damage checkpoint-dependent process mediated by ataxia 
telangiectasia and Rad3-related (ATR) and p53 tumor suppressor protein (74, 134, 135). Both 
ATR and free p53 localize in the nucleus with or without DNA damage. Despite the importance 
of XPA nuclear import for NER, it remains unresolved how XPA is imported into the nucleus 
from the cytoplasm.  
In this study, protein factors potentially involved in the transport of XPA through the 
nuclear pore complex (NPC) were investigated. We found that in the presence of the nuclear 
localization signal (NLS) of XPA, importin-α4 and importin-α7 served as the transport adaptors 
for the UV-induced nuclear import of XPA from the cytoplasm. Consistent with the requirement 
of ATR for the UV-induced XPA nuclear import, the role of importin-α4 in the import also was 
dependent on ATR. Surprisingly, however, XAB1 protein, suggested to be the GTPase involved 
in XPA nuclear import, showed no effect on the XPA nuclear import. Given the indispensable 
role of XPA in human NER, our findings demonstrate a cytoplasmic regulatory mechanism 
important for NER.  The therapeutic disruption of this transport process may provide a means of 
sensitizing cancer cells to chemotherapeutic drugs. 
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Materials and Methods 
Cell Culture, UV-Irradiation and Antibodies 
Cells were maintained in D-MEM supplemented with 10% FBS and 1% penicillin-
streptomycin. XPA-complemented cells were generated by stably transfecting H1299 cells with 
pcDNA3.1 vectors (Invitrogen) containing either wild type or NLS-mutated XPA cDNA with 
indicated mutations. All cell lines were grown at 37°C, 5% CO2. UV-C irradiation was 
performed using a 254 nm lamp at a flounce of 0.83 J/m
2
/sec. For blotting primary rabbit 
polyclonal antibody against XPA and mouse monoclonal antibody against poly (ADP-ribose) 
polymerase (PARP) were purchased from Santa Cruz Biotechnology Co. Antibodies against 
importins-α1, -α3, -α4, -α5, or -α7 were from Genetex Biotechnology Co. A FITC-conjugated 
primary mouse anti-actin antibody was obtained from Sigma Chemical Co. The anti-actin and 
anti-PARP antibodies were used in western blots to confirm successful subcellular fractionations 
and protein loadings. The rabbit monoclonal antibody against XAB1 is from Sigma Chemical 
Co. 
Immunoblotting 
Cells were harvested by scraping or trypsin-EDTA release, and re-suspended in lysis 
buffer [50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1x protease 
inhibitor cocktail (Roche)]. 2X SDS loading buffer was added to the lysates and the mixtures 
were heated at 100°C for 10 min to denature proteins. After running the samples in SDS-PAGE, 
proteins in the gel were transferred onto a PVDF membrane. The membrane then was blocked 
with 5% nonfat milk in TBST buffer and probed with specific primary and secondary antibodies. 
Chemiluminescence signal was captured using a Fuji Film camera, and the blot images were 
processed with Multi-Gauge 3.0 software. 
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RNAi 
XAB1 siRNA duplexes were purchased from Santa Cruz. siRNA duplexes targeting 
individual importin-α proteins in lung cells were successfully developed by Gabriel et al. These 
sequences were synthesized by Genepharm using the published sequences. The siRNA 
transfection reagent was purchased from Polyplus Transfection and the transfections were done 
by following their instructions as we described previously (135, 138). 
Subcellular Fractionation 
Subcellular fractionation was performed using the Proteo JET
TM
 cytoplasmic and nuclear 
protein extraction kit (Fermentas) by following the procedures suggested by the manufacturer. 
Briefly, 10 volumes of cell lysis buffer (with 1x protease inhibitors) were added to 1 volume of 
packed cells. After a short vortexing and incubation on ice for 10 min, cytoplasm was separated 
from nuclei by centrifugation at 500xg for 7 min at 4ºC. Isolated nuclei were washed once or 
twice with 500 μL of the nuclear washing buffer and then collected by centrifugation. The 
collected nuclear pellets were re-suspended in ice-cold nuclear storage buffer, and 1/10 volume 
of the nuclear lysis reagents was added to lyse the nuclei with rotation for 15 min at 4⁰C. A 
clarified nuclear lysate was obtained by centrifugation at 20,000xg for 15 min at 4ºC. In all of the 
fractionation experiments, western blotting of β-actin and PARP were assessed to check 
successful fractionation and cytoplasmic and nuclear protein loading, respectively. 
Immunoprecipitations 
Cells were lysed with NETN lysis buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 
mM EDTA, 0.5% Nonidet P-40) containing protease and phosphatase inhibitors (Thermo 
Scientific).  For each 2 mg of protein in the whole cell lysates 2 µg of primary antibody was 
added and the mixture incubated at 4°C with agitation overnight. Then, 15 µl of high-capacity 
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protein G-agarose (Thermo Scientific) was added and incubated for 2 hr at 4°C to capture the 
antibodies. After washing three times with NETN buffer, proteins was released from beads in 
SDS sample loading buffer and heat denaturation, resolved on 10% SDS-PAGE, and subjected to 
western blotting. Immunoprecipitation of XPA-binding proteins was conducted by mixing 1.0 μg 
of purified recombinant XPA protein with 2 mg of cell lysates from mock or UV-irradiated 
GM04429 (XPA
-/-
) cells; a goat monoclonal antibody to the C-terminal of XPA (Santa Cruz) 
then was added to the lysates and incubated at 4°C with agitation overnight. Protein G-agarose 
beads were added to capture the antibodies, washed 3 times with NETN buffer, and bound 
proteins eluted with SDS sample buffer, resolved on 10% SDS-PAGE, and subjected to western 
blotting.  
In Vitro Protein-Protein Interaction  
The immunoprecipitated importin proteins (prepared as above) were washed with 0.6 M 
NaCl (high salt wash) buffer (25 mM Tris-HCl [pH 8.0], 0.6 M NaCl, 0.2 % NP-40, 1 mM 
EDTA) containing protease inhibitors (Thermo Scientific) for 5 minutes at 4°C. After collection 
by centrifugation the beads and bound proteins were re-suspended in 200 µl of NETN lysis 
buffer. Then, 0.5 ug of purified XPA protein was added to each sample and incubated overnight 
at 4°C with agitation. The beads with bound proteins were collected by centrifugation and 
washed three times with NETN buffer, released in SDS sample buffer, resolved on 10% SDS-
PAGE and subjected to western blotting. 
Immunofluorescence Microscopy 
Transfected cells were grown on coverslips before the initiation of experimental 
treatments. After UV-C irradiation and specified recovering times, the cells were fixed with 
100% cold methanol and blocked with 15% BSA for 1 hr at room temperature. Proteins were 
82 
detected with primary antibodies and fluorescence-conjugated secondary antibodies (Invitrogen). 
Cells on coverslips were coated with prolong gold anti-fade reagent containing DAPI 
(Invitrogen) before microscopic examination using 100X magnification. 
 
Results 
The N-terminal NLS of XPA is Required for UV-Induced Nuclear Import 
To maintain a functional NER, XPA protein contains multiple functional domains for 
interaction with various other proteins, including RPA (replication protein A), excision repair 
cross-complementation group 1 (ERCC1), DNA damage-binding protein 2 (DDB2), and 
transcription factor II H (TFIIH), as well as chemical carcinogen-damaged or UV-damaged DNA 
(132) (Figure 4-1A). Among these domains, a NLS-like motif is located in the N-terminus (184) 
(Figure 4-1A). To determine whether the DNA damage-induced nuclear import of XPA depends 
on this NLS-like motif or whether XPA is co-imported with proteins containing a NLS, or 
imported by the so-called “alternative import mechanisms” (more than one mechanism) (136), 
two amino acids of the XPA NLS (184) were replaced with alanine (XPA-∆NLS) (Figure 4-1A). 
As shown in Figure 4-1B and Figures 4-S1A-C, no recombinant XPA protein (slower migration) 
was detected in the nuclear fractions of these mutated transfectants even after UV-irradiation. In 
comparison, after UV-irradiation the endogenous XPA increased in the nucleus as it decreased in 
the cytoplasm, and the recombinant wild-type XPA also accumulated in the nucleus (Figure 4-1B 
and Figures 4-S1A-C); indicating an UV-induced nuclear import of wild type XPA. Similarly, 
the immunofluorescence microscopy analysis showed that XPA-∆NLS remained in the 
cytoplasm even after the cells were irradiated with UV, while the wild-type XPA accumulated 
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normally in the nucleus (Figure 4-1C). These results suggested the dependence of the DNA 
damage-induced XPA nuclear import on the NLS motif. 
 
Figure 4-1. Nuclear localization of recombinant XPA requires an N-terminal NLS sequence  
A, A map of XPA protein illustrating the locations of the binding sites for various DDR proteins 
or for binding damaged DNA. The numbers refer to the first and last amino acid in the XPA 
protein. The XPA-∆NLS protein construct was made by changing the underlined amino acids 
within the NLS to alanine by PCR mutagenesis. B, Fractionation and western blotting 
demonstrates UV-induced XPA redistribution. Stably transfected H1299 cells were mock or UV-
C irradiated (20 J/m
2
) followed by a 2-hr recovery. The recombinant His
6
-V5-tagged XPA 
protein migrates slower than endogenous XPA allowing us to detect each XPA protein using 
XPA antibody. C, Immunofluorescence microscopy of recombinant XPA using antibody against 
the V5-tag portion of the recombinant XPA protein. H1299 cells were treated as in A. The 
84 
localization of XPA was assessed by immunofluorescence microscopy. The nuclei were stained 
with DAPI. 
Importin-α4 and Importin-α7 are Involved in the UV-Induced XPA Nuclear Import 
XPA has an N-terminal NLS (Figure 4-1), but its localization to the nucleus where it 
functions also depends on DNA damage and cell cycle stage (74, 135, 138). These observations 
indicate that there maybe two stages of XPA nuclear import: one occurs naturally in the absence 
of DNA damage, and another, the massive transport, is initiated by specific DNA damage 
signaling (74, 135, 138). Among the factors involved in the DNA damage-induced XPA import, 
those involved in the XPA transport through the NPC are unknown. Importin-α is a constituent 
of the classical nuclear import pathway. It acts as an adaptor protein that recognizes the NLS of 
cargo proteins and is transported as a ternary complex with importin-β into the nucleus (171, 
185) (Figure 4-2A). In humans, six importin-α isoforms are known. To identify the importin-α 
responsible for the UV-induced nuclear import of XPA, importin-α proteins in human lung cells 
were silenced by siRNA knockdown (Figure 4-2B). Subsequent subcellular fractionation 
analysis indicated that knockdown of importin-α4 or/and importin-α7 inhibited the XPA nuclear 
import (Figure 4-2C and 4-2D): XPA was present primarily in the cytoplasm without UV-
irradiation in control cells, and was transported into the nucleus after UV-irradiation in the 
control, importins-α1, -α3 or -α5 siRNA-knocked down cells (as indicated by the ratio of cXPA / 
nXPA). However, in cells with importin-α4 and/or importin-α7 silenced with siRNAs, significant 
amounts of XPA remained in the cytoplasm. 
The similar experiments also were carried out in the cells without UV treatment. As 
shown in Figure 4-S1D, without UV the siRNA-knockdown of importin α4 had no effect on 
XPA subcellular localization, indicating that the knockdown effect of importin α4 is UV-
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dependent. In contrast, knockdown of importin α7 showed some effect on XPA subcellular 
localization in the absence of UV, indicating that the knockdown effect of importin α7 is UV-
independent.  
 
Figure 4-2. Importin-α4 and -α7 are involved in the nuclear import of XPA 
A, A model for the movement of proteins into the nucleus. B, western blotting confirms the 
efficiency of siRNA knockdown of five importin-α proteins. H1299 cells were transiently 
transfected with siRNAs targeting individual importin-α proteins. Whole cell lysates were 
prepared 48 hours post-transfection and assessed by western blotting. C, Fractionation and 
western blotting assess the localization of XPA following UV-irradiation. H1299 cells were 
transfected with the indicated siRNA duplexes and, at 48 hours post-transfection, cells were 
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mock or UV irradiated (20 J/m
2
) and allowed a 2-hr recovery. Cytoplasmic and nuclear lysates 
were collected and analyzed by western blotting of XPA. The cXPA / nXPA numbers represent 
the amount of cytoplasmic XPA divided by the amount of nuclear XPA (cXPA / nXPA) and 
were calculated from repeated experiments. D, Similar experiments as in panel C, except that 
importin-α4 and importin-α7 were silenced simultaneously. 
 
Interaction of Importin-α4 and Importin-α7 with XPA  
Cargo protein with a classic NLS requires a direct interaction with importin-α to be 
transported through the nuclear pore complex (136, 171, 185-188) (Figure 4-2A). Further 
experiments were carried out to investigate if XPA forms complexes with importin-α4 or 
importin-α7. As shown in Figure 4-3A, XPA was co-immunoprecipitated with importin-α4 or 
importin-α7 antibodies. As a comparison, incubation of the cell lysates with protein G-agarose 
did not pull down any detectable XPA; suggesting that the presence of XPA in the 
immunoprecipitates is due to the interaction of importins-α4 or -α7 with XPA. Interestingly, 
while little XPA was found to bind to importin-α4 in cells prior to UV treatment, XPA was co-
precipitated with importin-α4 after ½ hr of recovering from 20 J/m2 of UV-irradiation (Figure 4-
3A, left panel), indicating the involvement of importin-α4 in the UV-induced XPA nuclear 
import. In contrast, however, XPA was co-precipitated with importin-α7 even in the absence of 
UV treatment (Figure 4-3A, right panel). These results were well consistent with those shown in 
Figures 2C and S1D. 
In a reciprocal experiment, cell lysates of XPA-deficient cells were supplied with 
recombinant XPA, incubated, and then the XPA was immunoprecipitated using anti-XPA 
antibody. As shown in Figure 4-3B, importin-α4 and importin-α7 were co-immunoprecipitated 
with XPA. In contrast, probing the same blot with importin-α1 and importin-α5 antibodies 
showed no bands in the western blotting (Figure 4-3B), indicating the preferred interactions of 
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XPA with importin-α4 and importin-α7. Interestingly, the in vitro binding of recombinant XPA 
to importin-α4 in cell lysates did not increase with UV irradiation (Figure 4-3B and Figure 4-4A-
c), a significant difference from the results in Figure 4-3A where endogenous proteins were co-
immunoprecipitated directly from cell lysates. This difference suggests that the binding affinity 
of XPA to importin-α4 itself is not affected by UV-irradiation of cells, but the binding is 
regulated in a UV-dependent manner, probably through the association with other cytoplasmic 
factors that may mask the XPA NLS (187, 189). Indeed, it was previously reported that the UV-
induced nuclear import of XPA was ATR-dependent (74). Consistently, here we showed that 
knockdown of ATR in cells reduced the amount of XPA interacting with importin-α4 (Figure 4-
3C). 
 
Figure 4-3. Importin-α4 and importin-α7 form complexes with XPA in cells 
A, XPA was detected in the protein complexes of importin-α4 or importin-α7 by western 
blotting. Immunoprecipitation of importin-α4 or importin-α7 also pulled down XPA in lysates 
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prepared as described in methods from H1299 cells which were UV-C irradiated (20 J/m
2
) and 
allowed a ½ h recovery. XPA was not pulled down with importin-α4 in lysates from cells that 
were mock treated.  B, A reciprocal experiment in which XPA was immunoprecipitated using a 
C-terminal XPA antibody. GM04429 (XPA
-/-
) cells were mock or UV-C irradiated (20 J/m
2
) 
followed by a ½ h recovery. Cell lysates were prepared as description in the material and 
methods and supplied with recombinant XPA protein. Immunoprecipitation of recombinant XPA 
was employed to assess whether the added XPA formed complexes with importin-α4 or 
importin-α7 proteins. C, Knockdown of ATR inhibited cellular interaction of XPA and importin-
α4. A549 cells were transfected with control (scrambled) or ATR siRNA. 72 hours post-
transfection cells were mock-treated or exposed to UV-C radiation (20 J/m
2
), followed by a 1/2-
hr recovery. The amount of XPA associated with importin-α4 was assessed by western probing 
of XPA that was co-immunoprecipitated with importin-α4. 
 
To further determine whether importin-α4 and importin-α7 directly or indirectly 
interacted with XPA, in vitro protein-protein interaction experiments were performed. As 
illustrated in Figures 4-4A and 4-4B, left panels, importin-α4 or importin-α7 was 
immunoprecipitated from cell lysates, and rinsed with the buffer containing 0.6 M NaCl to wash 
away interacting proteins as described previously (134, 190). Then purified recombinant XPA 
protein was added to the washed precipitates of importin-α4 or importin-α7, followed by further 
wash with regular binding buffer. As shown in the right panels of Figures 4-4A and 4-4B, the 
interaction of importin-α4 or importin-α7 with XPA was indeed direct.  
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Figure 4-4. Direct interaction of importin-α4 or importin-α7 with XPA in vitro 
A, In vitro interaction of importin-α4 and XPA was performed as description in the methods. A 
diagrammatic illustration of experimental procedures (a). H1299 cells were mock or UV-C 
irradiated (20 J/m
2
) followed by a ½ h recovery. Importin-α4 was immunoprecipitated as in 
Figure 4-3 A, and the precipitate rinsed with high salt (0.6 M NaCl) to wash away proteins 
interacting with importin-α4 without denaturation (b). Western blotting confirmed the efficiency 
of washing. Recombinant XPA was added and the interaction of importin-α4 and XPA was 
determined by western blotting following the pull downs (c). B, Similar to A, except that 
importin-α7 was immunoprecipitated. 
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Knockdown of XAB1, the Proposed GTPase, Did not Affect UV-Induced XPA Import 
Transportation of cargo protein in importin-α/-β protein complexes through the NPC 
requires energy dependent on the activities of GTPases (171, 188)(Figure 4-2A). In a yeast two-
hybrid system XAB1 was observed to bind XPA and it has been proposed to be the GTPase 
involved in XPA nuclear import (172).  To determine whether XAB1 protein is involved in 
human XPA nuclear transport, XAB1 was silenced by siRNA knockdown (Figure 4-5A), 
followed by subcellular fractionation of the cells and analysis by western blotting (Figure 4-5B) 
or by immunofluorescence detection of XPA (Figure 4-5C). Surprisingly, XAB1 knockdown had 
no effect on XPA nuclear import as compared with the control siRNA, suggesting that XAB1 
alone was dispensable for the UV-induced nuclear import of cytoplasmic XPA in human cells.  
 
Figure 4-5. Knockdown of XAB1 did not affect UV-induced XPA nuclear import 
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A, Western blotting confirmed siRNA knockdown efficiency of XAB1. A549 cells were 
transiently transfected with siRNA targeting XAB1. 72 hours post-transfection cells were mock 
treated or exposed to UV-C radiation (20 J/m
2
) followed by a 2-hr recovery. Whole cell lysates 
were prepared for western blotting analysis of XAB1. B and C, Demonstration that XAB1 was 
not needed for the nuclear localization of XPA in A549 cells. B, 72 hours post-transfection of 
control siRNA or siRNA targeting XAB1, cells were mock or 20 J/m
2
 of UV-C irradiated and 
allowed to recover for 2 hrs. Cytoplasmic and nuclear lysates were separated and loaded onto 
SDS-PAGE for analysis of XPA by western blotting. C, Immunofluorescence detection of XPA 
in the cells treated by UV-irradiation as in B. 
 
Discussion 
XPA has crucial functions in NER. It is essential to understand the mechanism by which 
XPA is imported into nucleus in response to DNA damage as NER depends on XPA functioning 
within the nucleus. In this study we identified the proteins involved in the nuclear import of 
XPA. We found that the DNA damage-induced nuclear import of XPA depended on an intact N-
terminal NLS within the protein. In addition, importin-α4 and importin-α7 proteins were 
involved in the nuclear import of XPA. We demonstrated that importin-α4 and importin-α7 
directly interacted with XPA, but in cells, the interaction of XPA with importin-α4 was UV-
induced and dependent on ATR. In contrast, the proposed GTPase XAB1 was not required for 
the DNA damage-induced nuclear import of XPA. We conclude that importin-α4 is the transport 
adaptor for the UV-induced XPA nuclear import (Figure 4-6). 
The observation that the nuclear import of XPA depended on its NLS in cells excludes 
the possibility that XPA was co-imported with other proteins containing a NLS, or imported by 
“alternative import mechanisms” (more than one mechanism) (136). This also suggests that the 
same NLS was utilized by different adaptors, importin-α4 and/or importin-α7, for transporting of 
XPA through the NPC. Interestingly, the binding of importin-α4 was largely induced by UV-
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irradiation ½ hour after exposure (Figure 4-3A, left panel). This suggests that the efficient 
nuclear import of XPA may occur as early as ½ hour post-UV-irradiation, consistent with the 
previous report (74). In contrast, substantial XPA-importin-α7 interaction was observed in the 
absence of DNA damage and, thus, the DNA damage appeared to have no effect on the 
interaction (Figure 4-3A, right panel). These results indicate that although both importin-α4 
and/or importin-α7 were required for XPA nuclear import, the requirement of importin-α4 was 
DNA damage-dependent while that of importin-α7 was not. Given that a small portion of XPA 
was present in the nucleus even without DNA damage, a possible scenario is that importin-α7 
could be involved in the nuclear import of XPA independent of DNA damage (Figure 4-S1D), 
while importin-α4 participated in the damage-dependent import of XPA.  
In addition, it has been shown previously that the DNA damage-induced nuclear import 
of XPA was cell cycle dependent, primarily occurring in S phase (135).  In G2-phase cells, XPA 
was localized to the nucleus regardless of DNA damage (135). Thus, it is possible that importin-
α7 is mainly responsible for nuclear import of XPA in G2 phase, while importin-α4 for S phase. 
This also may provide a possible explanation for the observation that knockdown of importin-α7 
had less effect on the XPA nuclear import because the percentage of G2 cells in an 
unsynchronized cell population is only about 15-20%.  
It previously was reported that the DNA damage checkpoint protein kinase ATR was 
involved in the regulation of the UV-induced XPA nuclear import (74). Interestingly, here we 
showed that the UV-induced binding of importin-α4 to XPA was also ATR dependent (Figure 4-
3C). Although ATR phosphorylates XPA at Ser196 in cells in responses to UV damage (73), we 
found that abolishing the phosphorylation of XPA had no effect on XPA-importin-α4 binding 
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(data not shown). This suggests that the dependence of the XPA-importin-α4 binding on ATR 
may occur via ATR regulation of other cytoplasmic factors involved in binding (74, 135). 
The NLS of XPA could not be efficiently recognized by importin-α4 in the absence of 
UV-irradiation (Figure 4-3A), likely due to the masking of the XPA NLS by the binding of other 
cytoplasmic factors. Elucidation of the details, though, beyond the scope of this study, merits 
future investigation (187, 189). Finally, the protein XAB1 is a GTP-binding protein that was 
identified as an interacting partner with XPA in a yeast two-hybrid system, and was proposed to 
be the GTPase involved in XPA nuclear import (172). However, our result showed that siRNA 
knockdown of XAB1 had no effect on the UV-induced nuclear import of XPA (Figure 4-5). This 
inconsistency could be due to the different environments within human cells and the yeast model 
system. Our data support that knockdown of XAB1 alone does not affect nuclear import of XPA 
in human cells. 
Also, it is worth noting the reports of immunofluorescence microscopic analyses that 
showed that XPA was fully localized to the nucleus even in the absence of DNA damage (184, 
191, 192). Given that these reports exclusively focused on images of individual cells transfected 
with XPA-expression constructs with or without GFP tags, the observations may not be 
inconsistent with the results of this study since XPA subcellular localization in unstressed cells is 
cell cycle dependent (135). Indeed we previously reported that XPA was predominantly 
localized to the nucleus in unstressed G2-phase cells (135). Though immunofluorescence images 
may accurately depict XPA distribution within an individual cell they do not reflect the 
subcellular localization of XPA within a population of cells as do our biochemical fractionation 
studies which represent the average XPA distribution within millions of cells (74, 135, 138). 
Also, in general G2 phase cells present the sharpest images of XPA location since the protein 
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appears more concentrated within the smaller, defined nuclear structure. In addition, we recently 
found that the same monoclonal anti-XPA antibody yields distinctly different XPA distribution 
patterns depending on the method of cell fixation. XPA is predominately located in the 
cytoplasm of undamaged cells fixed with methanol; in contrast, formaldehyde fixation resulted 
in a predominately nuclear localization in undamaged cells (data not shown). Apparently, the 
fixation method affects the antigen display with methanol revealing the same antigens as seen in 
the western blots of SDS-denatured proteins.  Formaldehyde rather than methanol was employed 
in the reports of a nucleus-only location for XPA (184, 191, 192). Even the basal level of nuclear 
XPA in the fractionation assays may vary somewhat between experiments, likely due to culture 
variations affecting the proportion of cells in the G2 phase (135, 138).  However, we observed a 
2.8-fold average increase in the XPA and importin-α4 interaction after UV irradiation in at least 
three independent experiments. Finally it is unknown if the GFP tag could have any effects on 
XPA in cytoplasm.  
Due to its indispensable role in human NER, including both global genome and 
transcription-coupled NER subpathways, XPA may serve as a potential target for sensitization to 
cancer chemotherapy (e.g. cisplatin) via manipulation of available nuclear XPA, either at the 
transcriptional or posttranscriptional level (73, 78-80, 123). Indeed, we previously showed that 
cisplatin, like UV-irradiation, induced XPA nuclear import (74, 138). Furthermore, recent studies 
indicate that targeting protein-trafficking pathways altered the sensitivity of melanoma to 
chemotherapy (137). The results from this study suggest that targeted disruption of the XPA-
importin-α4 complex could be a potential strategy to reduce the nuclear level of XPA given that 
NER occurs exclusively in the nucleus. Since the DNA damage-induced nuclear import of XPA 
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occurs primarily in S phase (135), the inhibition is expected to be specific to replicative cells, 
typically cancer cells, without interruption of XPA functions in cells in other cell cycle phases. 
 
Figure 4-6. Proposed mechanisms for the UV-induced XPA nuclear import. Imp α4 stands for 
importin-α4. 
 
Figure 4-S1. Requirement of NLS for XPA nuclear import in different types of cells 
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A-C, The same XPA constructs as in Figure 4-1B were transiently transfected into human HEK 
293T and GM02249 cells, as well as human primary fibroblasts BJ cells. Cells were mock or 20 
J/m
2
 of UV-C irradiated and allowed to recover for 2 hrs. Fractionation and western blotting 
assessed the subcellular localizations of XPA molecules. D, Effects of siRNA knockdown of 
importin-α proteins on XPA nuclear import in the absence of UV: H1299 cells were transfected 
with indicated siRNAs. At 48-hours post transfection, cellular fractions (C for cytoplasm, N for 
nucleus) were collected and western blotting was employed to assess the subcellular localizations 
of XPA. 
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DIFFERENTIAL DNA DAMAGE RESPONSES IN P53 PROFICIENT AND DEFICIENT 
CELLS: CISPLATIN-INDUCED NUCLEAR IMPORT OF XPA IS INDEPENDENT ON ATR 
CHECKPOINT IN P53-DEFICIENT LUNG CANCER CELLS (138) 
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Abstract 
Nucleotide excision repair (NER) and ataxia telangiectasia mutated (ATM)/ATR (ATM- 
and RAD3-related) DNA damage checkpoints are among the major pathways that affect the 
chemotherapeutic efficiency of anticancer drug cisplatin. Xeroderma pigmentosum group A 
(XPA) plays a crucial role in NER including both global genome repair (GG-NER) and 
transcription-coupled repair (TC-NER) subpathways, and has been a potential target for 
improving cisplatin therapeutic effects. We report here that XPA translocates from the cytosol 
into nucleus after DNA damage induced by UV irradiation and cisplatin, a mimetic of UV 
damage, in human cells with or without p53 deficiency. However, the damage response of XPA 
nuclear import was significantly slower in p53 deficient cells than in p53 proficient cells. The 
cells examined include the normal fibroblasts BJ, the human lung adenocarcinoma cells A549, 
and the p53-deficient non-small cell lung carcinoma cells H1299. We also found that while XPA 
is imported into nucleus upon cisplatin or UV damage in an ATR-dependent manner in p53-
proficient BJ and A549 cells, the ATR checkpoint pathway has no effect on the XPA nuclear 
import in p53-deficient cancer cells H1299. Similarly, the XPA nuclear translocation is not 
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regulated by ATM checkpoint or p38MAPK/MK2 either. Our findings suggest that NER is 
independent on the major DNA damage checkpoint pathways in H1299 (p53
-/-
) cells and that 
DNA damage responses are mechanistically different between p53-proficient and p53-deficient 
cells. Our results also highlight the possibility of selectively targeting XPA nuclear import as a 
way to sensitize cisplatin anticancer activity, but targeting ATR/ATM-dependent checkpoints 
may not be helpful in killing p53-deficient cancer cells. 
 
Introduction 
Chemotherapy is a critical clinical intervention for cancer patients. Cisplatin is one of the 
three most commonly used chemotherapeutic drugs (140). Cisplatin induces DNA intra- and 
inter-strand diadducts and DNA-protein crosslinks (142), which are the main cause of its 
cytotoxicity and hence its anti-cancer therapeutic effects. DNA repair of cisplatin-induced DNA 
damage is a major factor in modulating the therapeutic efficacy of cisplatin (141, 142). In 
humans, bulky DNA lesions produced by ultraviolet (UV) irradiation or by UV-mimetic agents 
such as cisplatin can be removed by nucleotide excision repair (NER) (7, 79). Therefore, the 
status of NER is an important factor in the success of chemotherapy using cisplatin (142, 143). 
The DNA repair protein xeroderma pigmentosum group A (XPA) is an indispensable 
factor for NER including both subpathways: transcription-coupled NER (TC-NER) and global 
genome NER (GG-NER). XPA is believed to verify the damage sites following initial 
recognition of a lesion, stabilize repair intermediates and recruit other NER factors, and be 
involved in recruiting other NER factors (124, 127-130, 193). To our knowledge, XPA has been 
consistently reported to be the major factor that limits the repair of cisplatin-induced DNA 
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damage (79, 194, 195). Regulating the XPA at transcriptional or posttranscriptional level would 
affect the NER activity and repair of UV- or cisplatin-induced DNA lesions (78, 79, 194, 195).  
The DNA damage checkpoints survey the structural integrity of the genome and 
coordinate multiple cellular pathways to ensure efficient removal of DNA damage. The ATM- 
and ATR-dependent checkpoint pathways are two major central components of the DNA damage 
response machineries in human cells. These pathways are comprised of a series of DNA damage 
sensors, signal mediators and transducers, and downstream effecter molecules (7, 13, 14). 
Among the downstream effectors of the ATR checkpoint, are three major checkpoint proteins of 
Chk1, p53 and p38 MARK/MAPK-activated protein kinase-2 (MK2) that can be directly or 
indirectly activated by ATR following UV irradiation (19, 152, 153) although p38MARK/MK2 
can be also activated independent of ATR (19).  
It is believed that the checkpoint pathways play an important role in regulation of NER 
processes (14, 15, 73-75). However, the underlying mechanisms remain elusive. Our previous 
studies indicated that the ATR checkpoint is required for regulation of DNA damage-induced 
XPA nuclear import and phosphorylation (73, 74). When the XPA nuclear translocation process 
is inhibited by disrupting the ATR-XPA interaction, DNA repair efficiency is significantly 
reduced (134). Our recent data (submitted elsewhere) also suggests that UV-induced XPA 
nuclear import is regulated by ATR through a p53 signaling pathway. Given that UV irradiation- 
and cisplatin-generating DNA lesions are repaired by NER in humans, and p53-deficient cancer 
cells rely on the p38MAPK/MK2 pathway for survival of DNA damages rather than the 
ATR/p53 signaling pathway (19, 139), it is of interest to determine whether the DNA damage-
induced XPA nuclear import occurs in p53 deficient cancer cells and whether the import is 
regulated by different checkpoint pathways in p53-proficient and deficient cancer cells. 
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Materials and Methods 
Cell Culture, Drugs, and Antibodies 
Cells were maintained in DMEM supplemented with 10% FBS and 1% penicillin-
streptomycin. All cell lines were grown at 37°C in 5% CO2. UV-C irradiation was performed 
using a 254 nm lamp at a flounce of 0.83 J/m
2
/sec. For time course analysis cells were further 
incubated at in culture conditions for the indicated amounts of time. Cisplatin were purchased 
from Sigma Chemical Co. and dissolved in 0.9% NaCl to make a 3 mM stock solution just 
before use. A final concentration of 30 uM was obtained by making a 1/100 dilution of the stock 
solution into culture medium. UCN-01 and SB203580 were purchased from Sigma Chemical Co. 
and Calbiochem Chemical Co., respectively. Both UCN-01 and SB203580 were dissolved in 
DMSO to make stock solutions of 1 mM and 10 mM which were diluted into cell culture 
medium at 250 nM and 10 μM, respectively. For western blotting, primary rabbit polyclonal 
antibody against XPA, mouse monoclonal antibody against PARP, rabbit polyclonal antibody 
against p53, mouse monoclonal antibody against Chk1, and goat anti-MK2 polyclonal antibodies 
were purchased from Santa Cruz Biotechnology Co.  A FITC-conjugated primary mouse anti-
actin antibody was obtained from Sigma Chemical Co.  
RNAi 
siRNA duplexes were synthesized by GenePharma Co. using the following sequences: 
MK2 siRNA: sense strand 5’-UGACCAUCACCGAGUUUAUdTdT-3’ and antisense strand 5’-
AUAAACUCGGUGAUGGUCAdTdT-3’; Chk1 siRNA: sense strand 5’-
ACAGUAUUUCGGUAUAAUAdTdT-3’ and antisense strand 5’-
UAUUAUACCGAAAUACUGUTGdTdT-3’; ATR siRNA: sense strand 5’-
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CCUCCGUGAUGUUGCUUGAdTdT-3’, and  antisense strand 5’-
UCAAGCAACAUCACGGAGGdTdT-3’; ATM siRNA: sense strand 5’-
CAUACUACUCAAAGACAUUdTdT-3’,  and  antisense strand 5’-
AAUGUCUUUGAGUAGUAUGdTdT-3’. The siRNA transfection reagent was purchased from 
Polyplus-transfection and the transfections were carried out by following manufacturer’s 
instructions. Briefly, cells were grown to 30-40% confluency and washed with PBS and 
antibiotic-free medium. siRNA duplexes were added to a small volume of FBS and antibiotic-
free medium and incubated with transfection reagent for 10 min. This mixture then was added to 
cells with FBS and antibiotic-free medium at a final siRNA concentration between 5-10 nM. 
After a 5-7 hour incubation, FBS and antibiotic were added into the transfection medium and 
incubation continued.  Experiments accessing the levels of protein expression or the effects of 
UV irradiation were initiated 48 or 72 hrs after transfection. For time course experiments after 
UV irradiation, siRNA-containing medium was temporarily removed during the UV irradiation. 
Subcellular Fractionation and Western Blotting 
Subcellular fractionation was performed using the Proteo JETTM cytoplasmic and 
nuclear protein extraction kit (Fermentas) by following the procedures suggested by the 
manufacturer. Briefly, 10 volumes of cell lysis buffer with protease inhibitors were added to 1 
volume of packed cells. After a brief vortexing and incubation on ice for 10 min, cytoplasm was 
separated from nuclei by centrifugation at 500 x g for 7 min at 4 ºC. Isolated nuclei were washed 
once or twice with 500 μL of the nuclei washing buffer and then collected by centrifugation. The 
collected nuclear pellets were re-suspended in ice-cold nuclear storage buffer, and 1/10 volume 
of the nuclear lysis reagents was added. The nuclei were lysed with shaking for 15 min at 4⁰C. 
Nuclear lysates were collected by centrifugation at 20,000 x g for 12 min at 4 ºC. The lysates 
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were then mixed with 2x SDS loading buffer, boiled for 10 minutes and loaded into SDS-PAGE 
for Western blot analysis. In all of the fractionation experiments, protein levels of β-actin and 
PARP were assessed as cytoplasmic and nuclear protein loading controls, respectively. 
 
Results 
XPA Translocates into the Nucleus From the Cytosol Upon Cisplatin- and UV-DNA Damage  
Consistent with previous observations (74, 134), the current data demonstrated that UV 
irradiation induced nuclear import of XPA in the normal foreskin primary cell line BJ, the human 
lung adenocarcinoma cell line A549, and a p53-deficient non-small cell lung carcinoma cell line 
H1299 (Figure 5-1A). Cisplatin is considered a mimetic of UV in inducing DNA damage that is 
exclusively repaired by NER. XPA is an indispensable factor of NER. To determine whether the 
nuclear import of XPA is part of the cellular response to cisplatin-induced DNA damage, BJ, 
A549 (wild-type p53) and H1299 (p53
-/-
) cells were incubated with cisplatin for indicated time 
periods (Figure 5-1B). The nuclear concentration of XPA started to increase no later than 4 hrs 
after cisplatin addition in BJ and A549 cells while to decrease in the cytosol. The nuclear 
translocation of XPA in H1299 cells occurred later than in BJ and A549 cells; however, 
significant nuclear import of XPA was observed after 8 hrs of incubation with cisplatin. With 20 
hrs of exposure to cisplatin cytoplasmic XPA protein started to recover to pre-exposure levels in 
A549 and BJ cells, even though the DNA-damage induced nuclear accumulation of XPA 
continued to the 24-hour time point. Different from BJ and A549 cells, the increasing of 
cytoplasmic XPA protein started after 24 hours of incubation with cisplatin, although a similar 
increasing of the nuclear XPA was observed. In agreement with the previous reports (167, 196), 
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cisplatin also induced overexpression and nuclear accumulation of p53 in A549 and BJ cells 
(Figure 1B). 
 
Figure 5-1. UV-C irradiation- and cisplatin-induced DNA damage induce nuclear import of XPA 
A, the normal foreskin cell line BJ, human lung adenocarcinoma epithelial cell line A549, and 
p53-deficient non-small cell lung carcinoma cell line H1299 were subjected to 20 J/m
2
 UV-C 
irradiated followed by a 2-hr recovery. Fractionation and western blotting were performed to 
assess the subcellular localization of XPA. B, the chemotherapeutic agent cisplatin also induced 
cytoplasmic-to-nuclear translocation of XPA. Normal primary cell line BJ, lung cancer cell line 
A549 and H1299 were incubated with DMSO (mock treatment) or 30 uM cisplatin for indicated 
time points. Fractionation and western blotting were performed to assess the expression and 
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intracellular localization of XPA. PARP and β-actin were assessed to check nuclear and 
cytoplasmic protein loading, respectively. 
 
Neither Chk1 nor MK2 is Required for Damage-induced XPA Nuclear Import 
Our recent study demonstrated that UV-induced XPA nuclear import is dependent on 
ATR/p53 signaling pathway in the p53-proficient cancer cells. However, the data in Figure 5-1 
showed no defects of XPA nuclear import in p53-deficient cancer cells H1299. Since both MK2 
and Chk1 kinase can transmit damage signals from ATR independent of p53 to arrest cell cycle 
progression, it of interest to determine whether Chk1 and/or MK2 are required for the UV-
induced nuclear import of XPA in H1299 cells. As shown in Figure 5-2A, no difference in XPA 
nuclear translocation was observed between the control siRNA and the Chk1 silencing cells, 
indicating that Chk1-mediated signaling is not required for the nuclear import of XPA. Similar 
result was also obtained for cells with MK2
 
knockdown by siRNA (Figure 5-2B). These results 
were further confirmed using two selective kinases inhibitors, UCN-01 and SB203580. UCN-01 
inhibits both Chk1 and MK2 activities while SB203580 mainly targets the p38/MK2 pathways. 
These inhibitors were incubated with H1299 cells to stop the signal transductions mediated by 
Chk1 and/or MK2. Consistent with the siRNA knockdown results, inhibition of the two kinases 
did not change the UV-induced XPA nuclear import (Figure 5-2C).  
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Figure 5-2.The DNA damage-induced XPA nuclear import is transmitted by unknown alternative 
pathways in the p53-deficient lung carcinoma cell H1299: Chk1 and/or MK2 are not required 
A, knockdown of ATR downstream checkpoint Chk1 has no effects on the XPA nuclear 
accumulation. H1299 cells were transfected with control siRNA or Chk1 siRNA. After 48hrs, 
transfected cells were mock or 20 J/m
2
 UV-C treated and further incubated for 2 hr to let the 
cells recover. The subcellular location of XPA was assessed with fractionation and western 
blotting. B, transient knockdown of MK2 kinase had no effects on the XPA nuclear translocation 
in the H1299 cells. Control siRNA or MK2 siRNA treated H1299 cells were mock-treated or 
irradiated with 20 J/m
2
 UV-C followed by a 2-hr recovery. Fractionation and western blotting 
were employed to analyze the location of XPA and the expression of MK2. C, A549 cells were 
pretreated with DMSO, 250 nM of UCN-01 or 10 uM of SB203580 for 1hr in culture. Cells were 
then mock-treated or irradiated with 20 J/m
2
 UV-C followed by a 2 hr recovery in the presence 
of the inhibitors. Cell fractionation and western blotting were performed to assess the 
translocation of XPA following UV-C irradiation. 
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ATR and/or ATM are not Required for Damage-Induced XPA Nuclear Import 
The observation that Chk1 and MK2 were not required for damage-induced XPA nuclear import 
in H1299 (p53
-/-
) cells implies that ATR may not be involved in regulation of nucleotide excision 
repair in p53 deficient H1299 cells. To test the hypothesis, ATR and ATM were depleted in 
H1299 cells. As shown in Figure 5-3, ATR and ATM were depleted by siRNA transfections 
individually (Figure 5-3A), or simultaneously (Figure 5-3B). However, the UV-induced cytosol-
to-nucleus translocation of XPA was not affected, as indicated by the equal amount of decreasing 
XPA in cytosol and increasing XPA in the nucleus between the control siRNA- and ATR/ATM 
siRNA-transfected cells. The result indicates that neither ATR nor ATM was required for the 
damage-induced XPA nuclear import. 
 
Figure 5-3. UV-induced XPA nuclear import is not regulated by ATR and/or ATM in the p53-
deficient lung carcinoma cell (H1299) 
A, silencing of the major cell cycle checkpoints ATR or ATM did not affect the UV-induced 
XPA import. In the control siRNA, ATR siRNA, and ATM siRNA transfected cells, UV-induced 
nuclear translocation of XPA was assessed using cell fractionation followed western blotting, 
after mock or 20 J/m
2
 of UV-C irradiation and a 2-hr recovery peroid. B, ATR and ATM were 
simultaneously depleted using transient siRNA transfections. Fractionation and western blotting 
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assay were employed to assess the UV-induced nuclear import of XPA after 2 hr recovering 
from mock or a 20 J/m
2
 UV-C irradiation. 
 
Discussion 
DNA damage checkpoints and DNA repair are two major types of cellular DNA damage 
response pathways and a close coordination between these two pathways is believed to be crucial 
for maintaining the genome integrity and stability in cells. Our recent studies indicated that 
ATR-dependent checkpoint pathway is required for regulation of the DNA damage-induced 
XPA translocation from cytoplasm to nucleus (74, 134). Interestingly, the results from this study 
indicate that although this ATR dependence occurs in p53-proficient normal and cancer cells 
treated with cisplatin or UV, it does not happens in p53-deficient lung cancer cells such as 
H1299 cells. This was further confirmed by the independence of XPA nuclear import on Chk1 
and p83MARK/MK2, two major downstream substrates of ATR checkpoint signaling. Given the 
fact that XPA is a crucial factor of NER, XPA-deficient cells exhibit the highest UV sensitivity 
among other NER factors (122), and XPA nuclear import is essential for the activity of NER(74, 
134), our findings suggest that NER is independent of ATR-dependent checkpoint in the p53-
deficient cancer cells. In addition, XPA nuclear import, thus likely NER, was also found 
independent of ATM checkpoint in the p53-deficient cancer cells. This implies that all the well-
known major DNA damage checkpoints appear to have no effect on NER in the p53-deficient 
cancer cells. In spite of this, the fact that XPA nuclear import is a DNA damage-induced event 
indicates that it is a regulated event in cells. We propose that an alternative checkpoint pathway 
may be responsible for the regulation. Taken together, our results suggest that the cellular DNA 
damage responses to cisplatin treatments are different in p53 proficient (A549) and deficient 
(H1299) cells. 
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One of the major challenges in treating cancer patients with cisplatin is the drug’s side-
effects: it introduces DNA damage to cancer cells while also causing damage to normal cells 
(140). One solution for this problem is to identify mechanistic differences of DNA damage 
responses between normal and cancer cells. In the current study, effort was made to define the 
unique mechanism of DNA damage responses in p53-deficient lung cancer cells as p53 is the 
most commonly mutated gene in human cancers, particularly the lung cancer. Thus three cell 
lines including the human normal primary cell line BJ, the p53-proficient lung cancer cell line 
A549, and the p53-deficient lung cancer cell line H1299 were treated with cisplatin or UV-C 
irradiation. A pronounced cytoplasm-to-nucleus translocation of XPA was observed in each of 
these cell lines (Figure 5-1), which is consistent with our previous observations on other types of 
cells treated with UV. Importantly, however, different from p53-proficient cells the damage-
induced XPA import is not dependent on ATR or other major known checkpoints in the p53-
deficient lung cancer cells-H1299 (Figure 5-2 and Figure 5-3). These observations reveal a 
mechanistic difference of DNA damage responses between p53-proficient and p53-deficient lung 
cancer cells. Evidently, identifying the novel regulation mechanism responsible for the damage-
induced XPA import in the p53-deficient cancer cells deserves further investigation in the future. 
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Abstract 
ATM and ATR are the two major DNA damage checkpoint kinases. Intriguingly, unlike 
ATM whose deficiency promotes carcinogenesis, inhibition of ATR has been shown to suppress 
UV carcinogenesis in mice. We hypothesized that ATR might contain an antiapoptotic activity 
unrelated to its checkpoint function. Indeed, here we show that besides its nuclear checkpoint 
functions, ATR in the cytoplasm is an antiapoptotic protein. Upon UV damage, cytoplasmic 
ATR translocates to mitochondria, blocking the recruitment of proapoptotic Bcl-2–associated X 
(Bax) protein to mitochondria and preventing the loss of mitochondrial membrane potential (ΔΨ) 
and apoptosis. Consistently, Bax-depletion significantly reduced the effect of ATR on ΔΨ. 
Remarkably, the cytoplasmic ATR exhibits no checkpoint kinase activity, a hallmark function of 
nuclear ATR. Inhibition of ATR’s kinase activity or silencing of ATRIP and Chk1 failed to 
affect Bax relocalization to mitochondria. Furthermore, knocking down p53 did not change the 
role of ATR in mitochondrial ΔΨ, indicating that the antiapoptotic role of ATR is independent of 
the proapoptotic p53. Our results reveal a novel checkpoint-independent antiapoptotic function 
of ATR at mitochondria in the cellular response to UV damage.  
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Introduction 
The human genome is constantly exposed to endogenous and exogenous DNA-damaging 
agents which may cause genomic instability and cancer. To counter these threats, cells have 
evolved multiple systems to signal DNA damage and to facilitate repair (1, 3, 5). Such responses 
include DNA damage checkpoints, activation of transcriptional programs, DNA repair and 
apoptosis. As the two major DNA damage checkpoint kinases from the phosphoinositide 3-
kinase-related protein kinases (PIKK) family, ATM (ataxia telangiectasia mutated) and ATR 
(ATM and Rad3-related) sense DNA damage, activate checkpoints, arrest cell cycle progression 
and facilitate DNA repair to restore DNA integrity (1, 7, 9, 10). Alternatively, apoptosis is 
activated to eliminate damaged cells if DNA damage is too severe (8, 11). ATM is primarily 
activated by DNA double-strand breaks (DSBs), while ATR is activated by recognizing the 
stretches of replication protein A (RPA)-coated single-stranded DNA (ssDNA) generated from 
DNA damage-induced replication stress or during the repair of certain types of DNA damage (9, 
10, 21). TopBP1 binds to the surface of the ATR–ATRIP (ATR-interacting protein) complex to 
activate ATR (63, 197). In addition to their specificities for different types of DNA insults, ATM 
and ATR also demonstrate coordinate and overlapping functions in DNA damage responses 
(DDR) (198, 199). 
Given the critical roles of ATM and ATR in DDR, it is believed that deficiency of ATM- 
or ATR-dependent checkpoint pathways may lead to genome instability and, thus, to cancer 
(198, 200). Indeed, ataxia telangiectasia (AT) patients have a high propensity for cancer, and 
knockout of ATM and/or BRCA1 promoted cancer (201-204). In contrast to ATM, ATR is 
essential for viability of mice and the cells from ATR-knockout mice died of apoptosis (25, 85, 
100). Furthermore, inhibition of ATR enhanced apoptosis through a p53-independent mechanism 
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(58, 101-105) regardless of ATR’s kinase activation in some cancer cells (105), and suppressed 
UV-induced carcinogenesis (102, 103). Also interestingly, a body of evidence from human 
epidemiologic and mouse model studies has demonstrated that caffeine consumption 
significantly decreased the risk of cancer (24, 106-116). Notably, caffeine is an inhibitor of cell 
cycle checkpoint pathways (111), but the inhibition may be independent of the kinase activities 
of ATM or ATR (117). Together the current evidence suggests that unlike ATM, ATR may 
contain an antiapoptotic activity and inhibition of ATR suppresses carcinogenesis. However, the 
molecular mechanism remains unknown. Given the potential antitumor activity of ATR 
inhibition, ATR has drawn attention as a promising target for anticancer chemotherapy, further 
underscoring the importance for understanding the mechanism.  
Since all its currently known functions, particularly as a checkpoint regulator, occur in 
the nucleus, ATR has been considered as a nuclear protein. However, the p53-independent 
apoptotic activity triggered by inhibition of ATR does not appear consistent with its role in cell 
cycle checkpoint regulation since loss of checkpoints leads to uncontrolled cell growth, genome 
instability or a p53-dependent DNA damage-induced apoptosis. We thus reasoned that ATR may 
contain a checkpoint-independent antiapoptotic function. To test this hypothesis, we investigated 
the cytoplasmic functions of ATR. We found that cytoplasmic ATR was an antiapoptotic protein 
which bound to mitochondria upon UV damage and inhibited the UV-induced recruitment of 
Bax to mitochondria. Importantly, this antiapoptotic function of ATR also was independent of its 
checkpoint activities. 
  
120 
Materials and Methods  
Cell Culture, UV irradiation, Drugs, and Antibodies 
All cells except ATR
+/+
 and ATR
flox/- 
cells
 
(a gracious gift from Dr. David Cortez, 
Vanderbilt University) were either purchased from American Type Culture Collection 
(Manassas, Virginia) or Coriell Cell Repositories (Camden, New Jersey). Cells were maintained 
in D-MEM supplemented with 10% FBS (SH3039603 from Thermo Scientific) and 1% 
penicillin-streptomycin, and grown at 37°C, 5% CO2. UV-C irradiation was performed using a 
254 nm lamp at a flounce of 0.83 J/m
2
/sec. Camptothecin (C9911) and hydroxyurea (H8627) 
were purchased from Sigma Chemical Co. Stock solutions of camptothecin (CPT) and 
hydroxyurea (HU) were made in DMSO and H2O, respectively, before addition to cell culture 
medium. The ATR kinase inhibitor, NU6027, was purchased from EMD Millipore (189299) and 
was used at a final concentration of 10 µM in cell culture medium. For western blotting and 
immunofluorescence microscopy primary goat polyclonal antibodies against ATR (sc-1887), 
ATRIP (sc-33410), and heat shock protein 70 (HSP70) (sc-1060), mouse monoclonal antibodies 
against DNA-PK (sc-135886), p53 (sc-6243), ubiquitin (sc-166553) or PARP (sc-8007) were 
purchased from Santa Cruz Biotechnology Co. Mouse monoclonal antibody against 
mitochondria heat shock protein 70 (MHSP70) (MA3-028) was purchased from Thermo 
Scientific. Rabbit polyclonal antibodies against ATR (A300-137A) and ATM (A300-299A) were 
purchased from Bethyl Laboratories, Inc, and were used in most of the western blotting. Mouse 
monoclonal antibody against lamin A/C (4777), rabbit polyclonal antibodies against Chk1 
phosphorylated at serine 345 (2348), and p53 phosphorylated at serine 15 (9284) were purchased 
from Cell Signaling Biotechnology Co. Rabbit polyclonal anti-sumo2/3 (ab81371) and anti-
sumo1 (ab5316) antibodies were purchased from Abcam. Antibody kits that recognize Bcl-2 
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proapoptotic family proteins were purchased from Cell Signaling Biotechnology Co. (9942). To 
verify that the DNA damage-induced and antibody-detected cytoplasmic slower bands were truly 
ATR in our western blotting, a different ATR antibody was purchased from Cell Signaling 
Technology (2790) and used to detect ATR. A FITC-conjugated primary mouse anti-actin 
antibody was obtained from Sigma Chemical Co. The anti-actin, anti-HSP70, anti-PARP and 
anti-lamin A/C antibodies were used in western blots to confirm successful subcellular 
fractionations and to normalize protein loadings.  
Immunoblotting 
Cells were harvested by scraping or trypsin digestion, and re-suspended in lysis buffer 
(50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1x protease inhibitor 
cocktail [Roche]). 2X SDS loading buffer then was added to the lysates and the mixtures were 
heated at 100°C for 10 min to denature proteins. After heating the samples in SDS-PAGE; 
gradient gels of 3-8% acrylamide (Invitrogen) were used for maximum resolution of the slower 
migrating cytoplasmic ATR band. Proteins were transferred from the gels onto PVDF 
membranes. The membranes then were blocked with 5% nonfat milk and probed with specific 
primary and secondary antibodies. Chemiluminescent signal was captured using a Fuji Film 
camera, and western blot images were processed with Multi-Gauge 3.0 software. 
RNAi and Plasmid Transfections 
 p53 siRNA duplexes were purchased from Santa Cruz (sc-29435). siRNA duplexes 
targeting other genes were synthesized by Genepharm using the following sequences: ATR 
siRNA, sense strand 5'-CCUCCGUGAUGUUGCUUGATT-3′ and  antisense strand 5′-
UCAAGCAACAUCACGGAGGTT-3′; ATM siRNA, sense strand 5′-
CAUACUACUCAAAGACAUUTT-3′  and  antisense strand 5′-
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AAUGUCUUUGAGUAGUAUGTT-3′; ATRIP siRNA, sense strand 5′-
AGAGAAACUGUUCCAAUUATT-3′ and antisense strand 5'-
UAAUUGGAACAGUUUCUCUTT-3'; Chk1  siRNA,  sense  strand  5'-
ACAGUAUUUCGGUAUAAUATT-3' and antisense strand 5’-
UAUUAUACCGAAAUACUGUTT-3'; Bax siRNA, sense strand 5′-
GACGAACUGGACAGUAACATT-3′ and antisense strand 5’-
UGUUACUGUCCAGUUCGUCTT-3’. The siRNA transfection reagent was purchased from 
Polyplus Transfection and the transfections were performed as described previously. Typically, 
cells were harvested at 48- or 72-hour post-transfection. Plasmids for transient expression of 
human wild-type ATR were gifts from Dr. Stephen J. Elledge at Harvard Medical School. The 
transfection of ATR plasmids into HCT-116 ATR
flox/-
 was done with jetPEI
TM
 transfection 
reagent (Polyplus) by following the company's instructions. 
Cytoplasmic and Nuclear Protein Extraction  
Subcellular fractionation was performed using the Proteo JET
TM
 cytoplasmic and nuclear 
protein extraction kit (Fermentas) by following the manufacturer’s procedure. Briefly, 10 
volumes of cell lysis buffer (with 1x protease inhibitors) were added to 1 volume of packed cells. 
After a short vortexing and incubation on ice for 10 min, cytoplasm was separated from nuclei 
by centrifugation at 500xg for 7 min at 4ºC. Isolated nuclei were washed once or twice with 500 
μL of the nuclear washing buffer and then collected by centrifugation. The collected nuclear 
pellets were re-suspended in ice-cold nuclear storage buffer, and 1/10 volume of the nuclear lysis 
reagent was added to lyse nuclei with rotation for 15 min at 4 ⁰C. The nuclear lysate was 
collected by centrifugation at 20,000xg for 15 min at 4 ºC. In all of the fractionation experiments, 
123 
western blotting of β-actin and PARP were assessed to check the quality of fractionation and 
protein loading. 
Mitochondria Isolation 
Mitochondrial isolation was performed using several mitochondrial extraction kits 
(Qiagen and Thermo) according to the manufacturer’s instructions. The Qiagen kit benefits from 
an additional density gradient purification step. Briefly, cells were suspended in lysis buffer to 
disrupt the plasma membrane. Plasma membranes and compartmentalized organelles, such as 
endoplasmic reticulum, mitochondria, and nuclei, remained intact and were collected by 
centrifugation at 1000xg for 10 min. The resulting pellet was resuspended in disruption buffer, 
repeatedly passed through a narrow-gauge needle (21 gauge), and re-centrifuged at 1000xg for 
10 min to pellet nuclei, cell debris, and unbroken cells. The supernatant that contains 
mitochondria was re-centrifuged at 6000xg for 10 min to pellet mitochondria. After removal of 
the supernatant, mitochondria were lysed with 1X SDS loading buffer and analyzed by SDS-
PAGE and western blotting. 
Immunofluorescence Microscopy 
For immunofluorescence microscopic detection of cellular proteins, cells were grown on 
coverslips before the initiation of experimental treatments. After UV-irradiation or treatments 
with chemical DNA damaging agents for indicated times, cells were fixed with 4% 
paraformaldehyde in PBS and blocked with 15% BSA in PBS for 1hr at room temperature. 
Proteins then were detected with primary antibodies and fluorescent-conjugated secondary 
antibodies (Invitrogen). Cells on coverslips were coated with prolong gold antifade reagent 
containing DAPI (Invitrogen) before microscopic examination using 100X magnification. 
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Mitochondrial Membrane Potential Assays 
MitoTracker red CMXRos (M7512 from Life Sciences) is a red-fluorescent dye that 
stains mitochondria in live cells and its accumulation is dependent upon an intact mitochondrial 
membrane potential. The staining of live cells is done by following their instructions. Briefly, 
cells were seeded at a confluence of 50% one day ahead of the DNA damage treatments. To 
prepare a stock solution, MitoTracker red CMXRos was dissolved in DMSO to a final 
concentration of 1 mM in a darkened room and used immediately. Right before usage, this dye 
was diluted to 200 nM in fresh growth medium without FBS. After incubation for the desired 
time periods following DNA damage treatments, the media was removed and prewarmed (37°C) 
staining solution was added to the cells and incubated for 30 minutes in the dark. Then, both the 
adherent and non-adherent cells were harvested, washed with PBS, and analyzed in an Accuri C6 
flow cytometer. 
The JC-1 Mitochondrial Membrane Potential Assay Kit was purchased from Cayman 
Chemical. The procedure for labeling cells was done by following the company’s instructions. 
The fluorescence of this dye was recorded by an Accuri C6 flow cytometer. 
In Vitro Kinase Activity Assay 
The in vitro kinase assay with ATR was performed as described previously. Briefly, 
endogenous ATR was immunoprecipitated from cytoplasmic or nuclear extracts of A549 cells 
irradiated with 40 J/m
2
 UV-C with a 2-hr post-irradiation recovery period. The ATR captured on 
protein G beads (53128 from Thermo Scientific) was washed thrice with PBS containing 0.05% 
NP40, followed by one wash with kinase buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 10 
mM MgCl2, 10 mM MnCl2, 2 mM DTT, 10% glycerol, 1X protease and phosphatase inhibitors, 
and 0.5 mM ATP]. Then, the immunoprecipitates were resuspended in 20 uL of kinase buffer 
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containing 10 uCi of [γ-32P] ATP and 0.5 µg of human GST-p53 protein (P05-30BG from Signal 
Chem). The kinase reaction was incubated at 30 ⁰C for 30 minutes and stopped by the addition 
of SDS loading buffer. Proteins were separated by SDS-PAGE and the radiolabeled proteins 
were visualized by gel scanning using a PhosphorImage scanner (Fuji, Stamford, CT). 
Immunoprecipitated endogenous ATR and the amount of GST-p53 in each sample were 
confirmed by western blotting.  
Flow Cytometry-Based Apoptosis Assays 
To measure the percentage of cells in the sub-G1 cell phase, propidium iodide solution 
was purchased from Sigma-Aldrich to stain nuclear DNA as described previously. Briefly, cells 
were grown in dishes to reach 70-80% confluence, trypsin-harvested, fixed with 70% ethanol at 
4°C, and then pelleted and re-suspended in PBS containing 20 µg/mL of propidium iodide and 
100 U RNase for 30 minutes at 37°C. After staining 30,000 cells were counted using an Accuri 
C6 flow cytometer to measure the DNA content. 
Apoptosis Analysis with Annexin V 
Phosphatidylserine exposure on the outer leaflet of the plasma membrane was detected by 
the FITC-Annexin V apoptosis detection Kit II (Invitrogen V13242) according to the 
manufacturer's instructions. Briefly, cells were pelleted following treatment and washed with 
PBS. Cells were then re-suspended in binding buffer at 1x10
6 
cells/ml, mixed with FITC-
Annexin V and incubated at room temperature for 15 minutes in the dark. The Annexin V-
positive cells were analyzed by flow cytometry. 
Statistical Analysis 
The statistical analysis of samples was performed with a two-tailed student’s t-test, and a 
p-value of less than 0.05 was considered as significant. 
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Results 
ATR Has a Role in Suppressing Mitochondria-Mediated Apoptosis Pathways 
To determine whether cytoplasmic ATR has effects on mitochondria-mediated apoptosis 
induced by UV irradiation, mitochondrial membrane potential (ΔΨ) was measured in HCT-116 
ATR
+/+
 cells and HCT-116 ATR-deficient cells (ATR
flox/-
)  (72) (Figures 6-1A, 6-1B and 6-1C). 
Mitochondrial membrane potential reflects the pumping of hydrogen ions across the inner 
membrane during electron transport and oxidative phosphorylation. Loss of ΔΨ is one of the 
events during apoptosis (205, 206). The loss of ΔΨ leads to increased membrane permeability 
and the release of mitochondrial components such as cytochrome c (205, 206). To measure ΔΨ, 
fluorescent dyes MitoTracker red CMXRos and JC-1 were used to measure ΔΨ integrity. These 
dyes passively diffuse across the plasma membrane and accumulate in active mitochondria, 
dependent upon the organelle’s membrane potential. As shown in Figures 6-1A-1C, the ATRflox/- 
cells experienced a significantly more rapid loss of ΔΨ than the ATR+/+ cells, especially for 
recovery times longer than 8 hours (Figures 6-1B and 6-1C). To confirm that the effect of ATR 
on mitochondrial ΔΨ is part of apoptosis, apoptotic cells were measured by annexin V staining 
and by counting cells in sub-G1 phases (Figures 6-1D and 6-1E). Indeed, significantly more 
ATR
flox/-
 cells went into apoptosis than the wild type cells. The role of ATR in regulating ΔΨ 
was further demonstrated by the siRNA knockdown of ATR in A549 cells (Figure 6-1F). In 
contrast, knockdown of ATM had no significant effect on ΔΨ as compared to the control in cells 
treated with either CPT (camptothecin) or UV (Figure 6-1F).  
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Figure 6-1. ATR deficiency/silencing lead to loss of mitochondrial membrane potential and 
promote apoptosis induced by DNA damage 
A, Western blotting assessed the expression of ATR in the HCT-116 ATR
+/+
 vs. ATR
flox/-
 whole 
cell lysates. B, The HCT-116 and ATR
flox/-
 cells were mock- or UV-C irradiated, allowed to 
recover for the indicated time periods, labeled with MitoTracker red CMXRos and analyzed by 
flow cytometry (≥ 30,000 cells measured). The quantitative data in the plot are from three 
independent experiments. C, More of the HCT-116 ATR
flox/-
 cells lost mitochondrial ΔΨ than the 
ATR
+/+
 cells as measured by flow cytometry analysis of JC-1 labeled cells 16-hours post-UV. 
Asterisk above bars indicates that a significant difference was found between the data from three 
independent experiments. D, Flow cytometer measurement of cells labeled with FITC-Annexin 
V in the HCT-116 ATR
+/+
 and ATR
flox/-
 cells (data generated by Moises Serrano); the values are 
an indicator of apoptotic cell death 16-hours post-UV. E, DNA content of each cell was 
measured by flow cytometer analysis at the indicated time points of UV recovery. Percentage of 
sub-G1 cells (with DNA content less than 2C) was calculated by dividing the number of cells in 
sub-G1 by the total number of propidium iodide positive cells. F, A549 cells were transiently 
transfected with control, ATR or ATM siRNAs, and then mock, UV or CPT treated. At 16 hours 
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post-induction, cells were labeled with MitoTracker red CMXRos and analyzed with flow 
cytometry. The asterisks means statistical differences were observed when compared with the 
control siRNA group (*, p ≤ 0.05; **, p ≤ 0.01). The western blot in the right panel is a 
confirmation of the silencing efficiency of the siRNAs in A549 cells at 48-hours post-
transfections. 
 
Since p53 is well-known for its role in regulating DNA damage-induced apoptosis, we 
next examined whether the role of ATR in maintaining ΔΨ depends on p53. As shown in Figure 
6-2, more ATR
flox/-
 cells lost ΔΨ than the ATR+/+ cells with a p53 knockdown background 
(ATR
+/+
, si-p53 cells versus ATR
flox/-
, si-p53 cells) (Figure 6-2). In contrast, depletion of p53 in 
ATR
+/+
 cells (ATR
+/+
, si-p53) significantly increased the number of cells with intact ΔΨ as 
compared with control siRNA-transfected ATR
+/+
 cells (ATR
+/+
, si-control) (Figure 6-2). This 
result is consistent with the well-established proapoptotic role of p53. Taken together, these 
results suggest that the antiapoptotic role of ATR is independent of p53. 
 
Figure 6-2. p53 is not required for the mitochondrial functions of ATR 
A, HCT-116 ATR
+/+
 and ATR
flox/-
 cells were transfected with control siRNA or with p53 siRNA. 
The expression of ATR and the efficiency of p53 knockdown were confirmed by western 
blotting (left). B, At 16-hour post-irradiation, cells were labeled with MitoTracker red CMXRos 
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and assessed by flow cytometry. A horizontal bracket indicates that a statistic difference was 
observed between the two indicated groups ((*, p ≤ 0.05; **, p ≤ 0.01). As expected, a 
significant reduction in the number of cells with intact ΔΨ was found for ATRflox/- cells versus 
ATR
+/+
 cells transfected with control siRNA, suggesting that ATR prevents cells from apoptosis. 
Similar results were obtained for cells with a p53 knockdown background (ATR
+/+
, si-p53 versus 
ATR
flox/-
, si-p53), indicating that the antiapoptotic role of ATR at mitochondria is independent of 
p53. In contrast, comparison between ATR
+/+
 cells transfected with control siRNA (ATR
+/+
, si-
control) and p53 siRNA (ATR
+/+
, si-p53) indicates that p53 depletion increased the number of 
cells with intact ΔΨ, suggesting that p53 promotes apoptosis following UV irradiation. 
 
ATR Inhibits the UV-induced Bax-Localization to Mitochondria through a Kinase-Independent 
Mechanism 
In order to determine the mechanisms for the ATR’s role in regulating mitochondrial ΔΨ, 
we examined the potential involvement of Bcl-2 family proteins as well as p53, the central 
players in the regulation of mitochondrial membrane permeability and apoptosis (8, 11, 43, 44, 
47). In addition to p53, these proteins included both proapoptotic and antiapoptotic proteins: 
Bax, Bcl-2-associated death promoter (Bad), BH3 interacting-domain death agonist (Bid), Bcl-2 
homologous antagonist killer (Bak), Bcl-2-like protein 11 (Bim), B-cell lymphoma 2 (Bcl-2), 
and induced myeloid leukemia cell differentiation protein (Mcl-1). As shown in Figure 6-3A, the 
ATR deficiency resulted in a significant increase of Bax localization to mitochondria in response 
to DNA damage in comparison with the ATR-proficient cells.  In contrast, the loss of ATR had 
no effect on mitochondrial localization of other factors including p53. The p53 protein also 
serves as a control in this determination: p53 was previously shown to localize to mitochondria 
to promote apoptosis (45, 47, 207). This DNA damage-induced mitochondrial translocation of 
p53 also was observed in Figure 6-3A. 
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Since ATR, a PIKK kinase, is an essential cell cycle checkpoint protein that 
phosphorylates hundreds of downstream proteins in responses to DNA damage (7, 60, 69), it is 
of great interest to determine whether the antiapoptotic activity of ATR at mitochondria is 
dependent on the kinase/checkpoint activity of ATR. Surprisingly, as shown in Figure 6-3B, 
inhibition of ATR kinase activity by the ATR kinase-specific inhibitor NU6027 did not lead to 
Bax-mitochondria translocation in ATR
+/+
 cells as it happened in ATR
flox/-
 cells. The inhibition 
of ATR kinase activity was confirmed by the attenuated phosphorylations of p53 at Ser15 and 
Chk1 at Ser345 in response to NU6027 treatment (Figure 6-3C). This result suggested a kinase-
independent role of ATR as an antiapoptotic protein at mitochondria in response to DNA 
damage. Furthermore, since ATRIP plays an essential role in ATR checkpoint activation (21, 
72), ATRIP was depleted by siRNA to inactivate ATR kinase activity (Figure 6-3E).  Similarly, 
Chk1, the major kinase substrate of ATR, also was depleted by siRNA (Figure 6-3E). As shown 
in Figure 6-3D, cells depleted with ATRIP or Chk1 failed to promote the mitochondrial 
recruitment of Bax in contrast to silencing of ATR.  
This kinase-independent role of ATR in mitochondria led to a question of whether the 
cytoplasmic ATR functions differently from the nuclear ATR as a kinase. To address this 
question, an in vitro 
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P-labeling assay was conducted to measure the kinase activity of 
cytoplasmic and nuclear ATR towards recombinant p53, a downstream kinase substrate of ATR 
(7, 69, 152). As shown in Figure 6-3F, the immunopurified cytoplasmic ATR from A549 cells 
with or without UV-irradiation failed to transfer the phosphate group to p53. In contrast, the 
immunopurified nuclear ATR phosphorylated p53 normally. These results suggest that the 
cytoplasmic ATR lacks the hallmark activity of ATR as a kinase. Also interestingly, we found 
that ATRIP is present almost exclusively in the nucleus and little in the cytoplasm (Figure 6-3G). 
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Silencing of ATRIP reduced the amount of nuclear ATR but did not affect the DNA damage-
induced formation of cytoplasmic ATR (Figures 6-3E and 6-3G). Together these data indicate 
that the antiapoptotic function of ATR is independent of its checkpoint kinase activity, and 
implies that the cytoplasmic ATR may be responsible for the antiapoptotic function at 
mitochondria. 
 
Figure 6-3. Cytoplasmic ATR which lacks checkpoint kinase activity inhibits the UV-induced 
Bax translocation to mitochondria 
A, HCT-116 ATR
+/+
 and ATR
flox/-
 cells were mock or 40J/m
2
 of UV-C treated and allowed to 
recover for the indicated times. Mitochondria (Mito) and cytosolic (Cyto) fractions were isolated 
from cytoplasm, loaded onto SDS-PAGE and apoptotic proteins were assessed by western 
blotting. MHSP70 and actin were checked for quality of the fractionation and for protein loading. 
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B, HCT-116 ATR
+/+
 and ATR
flox/-
 cells were mock (DMSO) or ATR inhibitor (ATR-KI; 10 µM 
NU6027) treated for 1-hour before irradiation with 40 J/m
2
 of UV and allowed to recover for 4 
hours. Cytoplasm from each cell treatment was fractionated into mitochondria (Mito) or cytosol 
(Cyto) and the association of Bax with each fraction was monitored by western blotting. C, The 
same treatment of cells were performed as in B. Phosphorylation of p53 on serine 15 and Chk1 
on serine 345 were monitored by western blotting to measure the checkpoint kinase activity of 
ATR. D, and E, HCT-116 ATR
+/+
 cells, 72-hours after transfection of ATR, ATRIP, or Chk1 
siRNAs, were mock or 40 J/m
2
 of UV irradiated and allowed a 4-hours recovery. The efficiency 
of the knockdowns is shown in E and the amount of Bax that was associated with isolated 
mitochondria is shown in D. F, A549 cells were mock- or UV-treated (40J/m
2
) followed by a 2-
hour recovery. Cytoplasmic (Cyto) and nuclear lysates (Nucl) were collected as described in the 
methods, endogenous ATR was immunoprecipitated, and in vitro phosphorylation of exogeneous 
GST-p53 or RPA was carried out to assess the checkpoint kinase activity of ATR (whole 
cytoplasmic ATR compared with one third of nuclear ATR) in the presence of [γ-32P] ATP 
(middle panel). Western blotting confirmed the presence of ATR and equal loading of GST-p53 
and RPA. Presented are representative data from at least three independent experiments. G, The 
occurrence of cytoplasmic ATR is independent of ATRIP.  A549 cells were transfected with 
control or ATRIP siRNAs for 48 hours before mock or 40 J/m
2
 UV irradiation and a 2-hour 
recovery.  The cells then were separated into nuclear and cytoplasmic fractions for analysis of 
ATR and ATRIP protein distributions. 
 
The Antiapoptotic Role of ATR Depends on Bax. 
Upon DNA damage, Bax translocates from the cytosol to mitochondria as an active form 
to initiate apoptosis (208, 209). Active Bax forms lipid pores in the mitochondria membrane, 
leading to a drop of the mitochondria membrane potential (210-212). Our data suggested that 
ATR may regulate the mitochondrial translocation of Bax and, thus, the antiapoptotic functions 
of ATR would depend on Bax. To confirm this, ATR
+/+
 and ATR
flox/- 
cells were transfected with 
scrambled or Bax siRNA (Figure 6-4A). Then, the capacity of ATR in maintaining an ATR-
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dependent ΔΨ (the ΔΨ difference between ATR+/+ and ATRflox/- cells) was measured in cells 
treated with UV (Figure 6-4B and 6-4C). The ΔΨ was determined by quantification of CMXRos 
and JC-1 staining. Indeed, knockdown of Bax in cells significantly reduced the ability of ATR to 
maintain a higher ΔΨ as compared to the cells transfected with control siRNA (Figure 6-4B and 
6-4C). 
 
Figure 6-4. Effects of ATR’s inhibition of mitochondrial membrane potential depend on Bax 
A, Western blotting confirms Bax silencing 48 hours after siRNA transfections in the HCT-116 
ATR
+/+
 and ATR
flox/-
 cells. B, and C, HCT-116 ATR
+/+
 and ATR
flox/-
 cells were transfected with 
control (scrambled) or Bax siRNA for 48 hours before UV irradiation. After treatments, flow 
cytometry was employed to determine the percentage of cells with intact mitochondria ΔΨ as 
indicated by labeling with MitoTracker Red CMXRos (panel B) or JC-1 (panel C). The capacity 
of ATR to regulate mitochondrial ΔΨ was determined by calculating the difference between 
ATR
+/+
 cells and ATR
flox/-
 cells (ΔΨ Differential = % ATR+/+ - %ATRflox/-). Statistical analysis 
was performed by comparing the capacities of ATR in the control siRNA and Bax siRNA 
transfected cells. Asterisks above bar means a significant difference was found. 
 
DNA Damage-Induced Translocation of ATR to Mitochondria 
To determine the mechanism for the antiapoptotic function of ATR and whether the 
cytoplasmic ATR plays a role, cells were treated with UV, CPT or hydroxyurea (HU), and then 
the subcellular fractions were analyzed. Interestingly, a form of cytoplasmic ATR was found to 
134 
migrate slower in 3-8% gradient SDS-PAGE than the nuclear or native ATR (Figure 6-5A). This 
DNA damage-induced form of cytoplasmic ATR was observed in multiple human cell lines 
including normal primary fibroblasts (BJ) and multiple cancer cells (A549, H1299, HeLa, HCT-
116, MCF-7) (data not shown). This form of ATR was detected only when cells were 
fractionated as described and the samples were separated in 3-8% gradient gels. We confirmed 
these observations by treating cells with increasing doses of UV (Figure 6-S1), or by irradiating 
cells with a single UV dose followed by recovery for different periods (Figure 6-S1). Meanwhile, 
a moderate decrease of nuclear ATR also was constantly observed (Figures 6-3F, 6-3G, 6-5A 
and 6-S1D). Several approaches were taken to verify that the slower-migrating band is ATR. 
First, the damage-induced formation of cytoplasmic ATR can be recognized by different ATR 
antibodies whose epitopes map to different region of ATR (Figure 6-S1C). Second, ATR
flox/-
 
cells were transfected with increasing amounts of wild-type ATR plasmids. A similar UV-
induced slower-migrating form of cytoplasmic recombinant ATR was observed in the transfected 
ATR
flox/- 
cells treated with UV (Figure 6-S2A). Third, this was confirmed further by mass 
spectrometry-based protein analysis of the two cytoplasmic ATR bands (Figures 5-S2B and 5-
S2C). In this analysis, both forms of the cytoplasmic ATR were immunoprecipitated by anti-
ATR antibody, visualized by Coomassie blue staining in SDS-PAGE (Figure 6-S2B) and 
identified by mass spectrometry (Figure 6-S2C). 
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Figure 6-5. DNA damage induced a slower-migrating form of cytoplasmic ATR which localizes 
to mitochondria 
A, A549 cells were mock treated, UV-C irradiated (20 J/m
2
, followed by 2 hour recovery), 
treated with CPT (10 µM for 4 hour), or incubated with HU (2 mM for 20 hour). Fractionation 
and western blotting assessed the formation of cytoplasmic ATR which exhibited a slower 
electrophoretic mobility. Heat shock protein 70 (HSP70), actin, PARP, and lamin A/C were 
probed to ensure the quality of fractionation and protein loading. B, A549 cells were treated with 
20 J/m
2
 of UV-C and left to recover for 0, 0.5 or 2 hours. Following recovery, mitochondria were 
isolated as described in the Methods. Mitochondria, cytosolic lysate without mitochondria (top 
panel) and total cytoplasmic proteins (bottom panel) were analyzed by western blotting. The 
presences of MHSP70 and actin were probed as quality controls for the experiment. The UV-
induced formation of cytoplasmic ATR seemed happening very fast after UV, as there was a 
slow migrating ATR formed when the cells were processed immediately post-UV irradiation 
(less than 5-minutes). C, A549 cells were seeded on coverslips one day before cells were mock- 
or UV-C irradiated (20 J/m
2
) and allowed a 2-hour recovery. To determine if ATR localized to 
mitochondria, cells were co-stained with anti-ATR antibody and either MitoTracker Red 
CMXRos or anti-MHSP70. The fluorescence of MHSP70 and DAPI were merged for labeling of 
mitochondria and nuclei respectively. For quality control of staining, A549 cells were transfected 
with ATR siRNA to confirm that the detected anti-ATR antibody fluorescence is from ATR 
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exclusively. Presented images are representative data from at least three independent 
experiments. 
 
Next we examined the subcellular localization of the cytoplasmic ATR. To this end, 
mitochondria were isolated from cells using methods described previously (213, 214). As shown 
in Figure 6-5B, an accumulation of slower migrating ATR occurred in the mitochondrial fraction 
following UV-irradiation. Correspondingly, the cytosolic fraction without mitochondria showed 
a dramatic reduction of the slower migrating ATR after UV-irradiation compared to the total in 
the cytoplasm (Figure 6-5B top vs. Bottom panels). These results strongly suggest that UV 
induced a translocation of slower migrating cytoplasmic ATR to mitochondria. In addition, we 
co-stained ATR and mitochondria in cells using mitochondrial heat shock protein 70 (MHSP70) 
or MitoTracker red CMXRos. As shown in Figure 6-5C, significantly more co-localization 
signals (yellow) were observed in the merged fluorescent images of the UV-irradiated cells than 
in non-irradiated cells. Knockdown of ATR confirmed that the observed ATR 
immunofluorescence signal was from ATR exclusively (Figure 6-5C). We also investigated the 
localization of DNA damage checkpoint kinase ATM in the cytoplasm. Interestingly, little ATM 
was detected in the cytoplasm and so was its co-localization with MHSP70 (Figure 6-S3). 
 
Discussion 
Although inhibition of ATR has been demonstrated to promote apoptosis and suppress 
carcinogenesis previously (58, 102-104, 144), it is generally believed that the observed effects of 
ATR inhibition are mediated by the hallmark checkpoint functions of ATR in the nucleus. In this 
study we showed that the ATR located in the cytoplasm has a checkpoint kinase-independent 
role in inhibiting the Bax-mediated apoptotic pathways following UV irradiation. This 
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antiapoptotic role of ATR was clearly independent of its checkpoint response functions. The 
cytoplasmic ATR did not exhibit the hallmark kinase activity of nuclear ATR. Instead, it had a 
direct role in regulating the mitochondrial membrane potential ΔΨ mediated by Bax, and 
inhibition of ATR kinase activity had no effect on the mitochondrial ΔΨ stabilization function of 
cytoplasmic ATR. Our finding reveals a novel role of ATR in the cytoplasm as an antiapoptotic 
protein which is directly involved in mitochondrial metabolism in cellular responses to DNA 
damage. 
          As a major DNA damage-checkpoint protein kinase, activation of ATR results in cell cycle 
arrest. Our results indicate that in addition to its checkpoint functions, ATR also has a direct role 
in suppressing mitochondria-mediated apoptosis. Remarkably, the cytoplasmic ATR is distinct 
from the nuclear ATR in many aspects. Unlike nuclear ATR, cytoplasmic ATR contains no 
checkpoint kinase activity toward p53 and RPA (Figure 6-3F). Also, different from nuclear ATR 
which is activated primarily by replication stress-inducing DNA damage such as UV damage, 
cytoplasmic ATR shows antiapoptotic activity in response to various types of DNA damage 
including DNA double-strand breaks induced by CPT and HU (Figures 6-1F and 6-5A). Thus, it 
is not surprising that cytoplasmic ATR exhibits different activity than does the kinase-active 
nuclear ATR. All these observations suggest that ATR has two distinct functions delivered by 
two different forms of ATR during DNA damage responses. Upon DNA damage, the nuclear 
ATR kinase is involved in activation of cell cycle checkpoints and DNA repair, while the 
cytoplasmic ATR stabilizes mitochondria, preventing activation of apoptosis. It is obvious that 
the synergetic action of these two events promotes the biological stability of the cells under the 
stress of DNA damage.  
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 Also interestingly, under unstressed conditions, ATR appears to maintain a much lower 
level in the cytoplasm than in the nucleus. Although the cytoplasmic level of ATR might be 
increased via translation upon DNA damage, it appears that the increase could be more rapid by 
export of existing nuclear ATR. Given the large size (301 kDa) of the protein, nuclear export 
allows a much quicker response to DNA damage than does transcription followed by translation 
(Figure 6-S4A). 
            Another interesting observation of this study is that a new form of cytoplasmic ATR 
electrophoretically migrates slower than nuclear ATR in SDS-PAGE, implying that a possible 
posttranslational modification (PTM) to the protein may occur. Although ATR is known to 
undergo phosphorylation upon DNA damage (70, 119), phosphorylation would not change the 
electrophoretic mobility of ATR (70, 119) (Figure 6-S4B). In efforts to characterize the 
cytoplasmic ATR, we additionally examined the possible PTMs including glycosylation (Figures 
6-S4B and 6-S4D), ubiquitinylation (Figure 6-S5A), which is required for translocation of p53 to 
mitochondria (213), sumoylation (Figure 6-S5A), palmitoylation (Figure 6-S5B), and prenylation 
(Figure 6-S5C). Unfortunately, none of these modifications was found to be responsible for the 
slower electrophoretic mobility of cytoplasmic ATR. N-myristoylation is also unlikely as the 
sequence of ATR contains no targeting amino acid for N-myristoylation, although N-
myristoylation happens on BID and is required for its mitochondria membrane association and 
proapoptotic functions (215).  Furthermore, protein translation inhibition by cycloheximide or 
puromycin had no effect on cytoplasmic ATR formation following UV damage (Figure 6-S4A), 
suggesting that the nuclear ATR is not a proteolytic product of the slower migrating cytoplasmic 
ATR assuming the latter to be the nascent ATR. The translation-inhibition data also indicate that, 
once formed, the cytoplasmic ATR is relatively stable. These results suggest that ATR might 
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undergo an unknown DNA damage-induced molecular modification to form the slower 
migrating form. Identifying the modification, though out of the scope of this study, would be an 
important future effort to fully understand the role of ATR in DNA damage responses. 
Supplementary Figures 
 
Figure 6-S1. DNA damage induced formation of a slower-migrating cytoplasmic ATR in a dose- 
and time-dependent manner 
A, A549 cells were treated with increasing doses of UV irradiation, allowed to recovery for 2 
hours; alternatively, cells were treated with 20 J/m
2
 of UV and allowed to recover for different 
time periods. Cytoplasmic proteins were collected and assessed by western blotting of ATR and 
actin. B, Cytoplasmic ATM and DNA-PK do not exhibit electrophoretic mobility changes in 
response to DNA damage. The same blot as in Figure 6-S1A was successively probed with ATM 
and DNA-PK antibodies and shows no migration change of ATM or DNA-PK in response to 
DNA damage. C, A different ATR antibody was purchased from Cell Signaling which 
recognizes ATR at residues flanking the 1465 region (different from the Bethyl ATR antibody 
whose epitope maps on N-terminus of ATR at the 420 region), and confirmed the damage-
induced formation of slower cytoplasmic ATR. D, The increasing total amount of cytoplasmic 
ATR (two bands) correlates with a decrease of nuclear ATR in DNA damage responses. A549 
cells were treated with 40J/m
2
 of UV and allowed to recover for indicated times. Cytoplasmic 
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and nuclear lysates were collected by fractionation and analyzed by western blotting of ATR. 
Nuclear PARP (cleaved PARP is an 89 KDa lower molecular weight band) and cytoplasmic 
actin were probed to check quality of loading. A quantitative representation of normalized ATR 
levels is shown in panel E.  
 
Figure 6-S2. Confirmation of the identity of cytoplasmic ATR 
A, HCT-116 ATR
+/+
 or ATR
flox/-
 cells were transiently transfected with the indicated amount of 
pcDNA3.1 vectors containing wild-type ATR. Transfected cells were mock or UV-C irradiated 
(40 J/m
2
) followed by a 2-hr recovery. Cytoplasmic lysates were loaded onto SDS-PAGE and 
analyzed by western blotting of ATR. B, Preparation of samples for protein identification by 
mass spectrometry. A549 cells were mock or UV-C irradiated (40 J/m
2
) and allowed a 2-hr 
recovery. ATR was immunoprecipitated from cytoplasmic lysates prepared from forty 150 mm 
dishes of A549 cells. Proteins attached to protein G beads were released by boiling in SDS 
loading buffer, separated by SDS-PAGE, and stained with coomassie blue (left). The indicated 
ATR bands were excised and subjected to trypsin proteolysis for generating small peptide 
fragments amenable for protein identification by MS/MS mass spectrometry. 10% of the sample 
amount was loaded in SDS-PAGE and analyzed by western blotting of ATR (right). C, Mascot 
search results confirmed the presence of ATR in the two protein bands highlighted in panel A 
141 
(keratins are a common contamination during sample preparation for mass spectrometric 
analysis). 
 
Figure 6-S3. Immunofluorescence signal of ATM does not show colocalization with 
mitochondria 
A549 cells were mock or UV-C irradiated (40 J/m
2
) with a 2-hr recovery, or treated with 10 µM 
CPT for 2 hr. The localization of ATM and mitochondria were resolved by immunofluorescent 
staining of ATM and MHSP70; staining of MHSP70 labels the mitochondria. 
 
Figure 6-S4. The DNA damage-induced migratory change of cytoplasmic ATR is neither due to 
phosphorylation nor to glycosylation 
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A, A549 cells were pre-treated with 10 µg/mL of cycloheximide (CHX) or 2 µg/mL of 
puromycin (Puro) for 4 hours. Cells then were mock or UV-C irradiated (40 J/m
2
) and allowed a 
2-hr recovery before cytoplasmic lysates were collected and analyzed by western blotting of 
ATR and p53. The lack of detectable p53 in the drug-treated samples indicates the effectiveness 
of the protein synthesis inhibitors. B, A549 cells were mock or UV-C irradiated (20J/m
2
) and 
allowed a 2-hr recovery. ATR was immunoprecipitated from cytoplasmic lysates. The 
immunoprecipitates were treated with enzyme buffer alone (Mock), lambda phosphatase or the 
deglycosylation enzyme mix. Western blotting was employed to assess the results. Detection of 
the faster-migrating IgG heavy chain indicates that the glycosylation treatment was complete. C, 
As a control for the phosphatase experiment in panel B, hyper-phosphorylated RPA32 was 
induced by UV-irradiation of duplicate A549 cell cultures before treatment of the lysates with 
phosphatase to confirm the complete removal of phosphate groups. The RPA32 was detected by 
western blotting. D, The protein fetuin which contains sialylated N-linked and O-linked glycans, 
was employed as a positive control for degylcosylase activity. SDS-PAGE separation and 
coomassie blue staining confirmed a faster migrating form of fetuin after deglycosylation 
reactions.   
 
Figure 6-S5. Ubiquitination, sumoylation, palmitoylation or prenylation are not the cause of the 
slower migrating cytoplasmic ATR 
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A, A549 cells were mock or UV-C irradiated (40 J/m
2
) and allowed a 2-hr recovery. ATR was 
immunoprecipitated from cytoplasmic or nuclear lysates, separated by SDS-PAGE, and assessed 
by western blotting of ubiquitin (Anti-UB), sumo (Anti-SUMO), and ATR. B, A549 cells were 
pre-incubated with 100 μM of 2-bromopalmitate (2-BP) for 4 hours to inhibit protein 
palmitoylation. Cells then were mock or UV-C irradiated (20 J/m
2
) followed by a 2-hr recovery. 
Fractionation and western blotting assessed formation of cytoplasmic ATR. C, A549 cells were 
pre-incubated with 1µM of pravastatin (Prava) and/or zoledronic acid (Zole) for 20 hr to inhibit 
protein prenylation. Cells then were mock or UV-C irradiated (40 J/m
2
) and allowed a 2-hr 
recovery. Fractionation and western blotting assessed formation of cytoplasmic ATR. 
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CHAPTER 7 
 
SUMMARY AND CONCLUSIONS 
 
Integrity of the human genome must be maintained for cells to ensure proper cellular 
functions and survival from one generation to the next. In cells the coordination of multiple 
mechanisms is required to detect and remove damaged DNA or to eliminate damaged cells in 
order to prevent genomic instability. Among these pathways are nucleotide excision repair 
(NER) and ATR-mediated DNA damage checkpoint. The NER pathway removes DNA adducts 
that are generated by a variety of genotoxic reagents (7, 14) such as UV-irradiation. The nuclear 
ATR-mediated DNA damage checkpoints survey the genome for replicative stresses and arrest 
cell cycle progression allowing time for repair (7, 9, 10, 14), while cytoplasmic ATR inhibits 
DNA damage-induced apoptotic cell death. Together, these 3 pathways are the major 
mechanisms that cells have evolved to handle UV-induced DNA damage in order to prevent 
mutation and genome instability. 
A general requirement for these pathways to be fully functional is to have the DNA 
damage signaling and repair proteins properly modified and located at sites where they can carry 
out their functions (6, 7). For instance, the proper localization of DNA repair proteins to nuclear 
chromatin and the formation of higher order DNA-protein and protein-protein complexes at 
damage sites are required for DNA damage recognition and for DNA repair to occur (5-7). One 
such mechanism that is revealed by this dissertation is the regulation of NER by ATR via 
modulation of XPA phosphorylation and nuclear importation (73, 74, 78-80, 123). Functionally, 
XPA is believed to play roles in verifying DNA damage, stabilizing repair intermediates, and 
151 
recruiting other NER factors to the damaged DNA (76, 124-130). To accomplish these functions 
XPA has to enter the nuclei and gets phosphorylated in order to be fully functional in nuclear 
DNA repair, a process that is mediated by DNA damage checkpoint ATR (73, 74, 133, 135, 
138). In addition to the requirement of proper modifications and/or localization of repair proteins 
to chromatin for DNA repair, the central players in mitochondrial membrane permeability and 
apoptosis (8, 11, 43, 44, 47, 209, 211) are needed at the mitochondria for their direct roles. 
Studies in this dissertation revealed a novel regulation of these central players that is mediated by 
cytoplasmic ATR. Our data suggest that in response to DNA damage cytoplasmic ATR localizes 
to mitochondria and plays a kinase-independent role in inhibiting the localization of Bax protein 
to mitochondria and, thus, inhibits apoptosis. A summary of the roles of ATR in regulation of 
NER and apoptotic cell death, which were revealed by this dissertation, are discussed by chapters 
as following. 
Chapter 2: ATR Interaction and/or Phosphorylation of XPA is Required for DNA Repair 
Recent studies have demonstrated that the ATR-dependent checkpoint pathway may 
coordinate with NER via regulation of XPA localization and/or phosphorylation of XPA to 
promote DNA repair (73, 74). To further understand whether the phosphorylation of XPA by 
ATR is required for removal of UV-DNA damage, as well as how the ATR-XPA interaction 
occurs, is biologically significant.  I investigated whether ATR interaction with and/or 
phosphorylation of XPA were required for DNA repair (134) (presented here in Chapter 2). 
Using a mass spectrometry-based protein footprinting method, it was previously found in this lab 
that ATR interacts with a helix-turn-helix (HTH) motif in the minimal DNA-binding domain of 
XPA where an ATR phosphorylation site (serine 196) is located (134). A surface lysine residue 
of XPA, K188, was protected from biotin modification following the binding of XPA to ATR, 
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and when K188 was mutated to an alanine, the ability of XPA to bind to ATR was abolished. 
However, mutation of K188 to glutamic acid did not change the ATR-XPA complex formation, 
suggesting other resides on the HTH motif mediate the complex formation and that K188 may be 
necessary for stabilization of the α-helix domain. In cells I found that disruption of XPA-ATR 
interaction by a K188A mutation of XPA inhibited the ATR-dependent nuclear import and 
phosphorylation of XPA and reduced the ability of XPA to repair UV-DNA damage. These 
observations highlight the significance of XPA and ATR interaction in the regulation of NER by 
ATR. 
Phosphorylation and the directed-nuclear import of XPA represent 2 possible 
mechanisms for regulation of NER by the ATR-dependent DNA damage checkpoints (Chapter 
2). Cells with the phosphorylation-deficient XPA were less capable of repairing UV-induced 
CPDs instead of 6-4PPs, although no difference was found on its nuclear import. 6-4PPs account 
for ~25% of the damage generated by UV-C irradiation and can be quickly removed by NER 
(within 4-hours in healthy cells); while CPDs represent ~75% of total DNA lesions caused by 
UV-C and are repaired at a much slower rate (as long as 24-hours in many cells). Therefore, a 
basal XPA level in the resting nucleus, as well as the immediate ATR-directed XPA import 
following UV (74) could be sufficient to support the rapid removal of 6-4PPs so that no 
significant effects were observed. However, repair of CPDs needs more XPA molecules for a 
much longer period of time, and a significant delay in repair was observed due to the deficiency. 
Indeed, research by Lee et al. demonstrated that ATR enhanced XPA protein stability via 
phosphorylation of XPA, and the stability of XPA controlled the efficiency of UV-induced DNA 
repair (133). Within an earlier recovery time point (90 min after UV irradiation) than used in our 
studies, this even group was able to detect a subtle but significant change in 6-4PPs repair 
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kinetics that was affected by phosphorylation of XPA. In summary, the ATR-directed nuclear 
import of XPA represents a quick responding mechanism of NER for DNA repair, while 
phosphorylation of XPA prevents XPA degradation (133) and is responsible to maintain the 
persistent function of the NER. 
Chapter 3: XPA-Mediated Regulation of Global Nucleotide Excision Repair by ATR Is p53-
Dependent and Occurs Primarily in S-Phase 
After we had published our initial work on the regulation of NER via posttranslational 
modification and directed-nuclear import of XPA by ATR, another group reported a requirement 
of ATR in maintaining NER activity primarily during S phase in human cells (15, 75). This S-
phase regulation of NER by ATR leads to questions whether the ATR-directed nuclear import of 
XPA upon DNA damage also is cell cycle specific and downstream targets of ATR are involved 
in the UV-induced XPA import. Therefore, the study described in Chapter 3 was aimed to 
investigate ATR-directed XPA nuclear import by identifying the downstream mediators involved 
in the ATR kinase-dependent XPA nuclear import and the cell cycle-dependent DNA repair. We 
examined whether any of the major downstream checkpoint substrates of ATR, such as p53, 
Chk1, or MK2, are involved in the regulation of the UV-induced XPA nuclear import. We found 
that not only was the p53 protein itself necessary, but also, the transcriptional function of p53 
and the DNA damage signaling via p53-ser15 phosphorylation were important for UV-induced 
XPA nuclear import. The effect of p53-ser15 phosphorylation appears to be similar as that of the 
p53 inhibitor pifithrin-α (167-169), which inhibited the transcriptional activity of p53 and the 
UV-induced XPA nuclear import.  
With our strategies a cell cycle-specific regulation of NER by ATR is unveiled as in 
Chapter 3. Our results suggest that the UV-induced XPA nuclear import happens predominately 
154 
in S phase, while the XPA nuclear import in G1 and G2 phases is largely independent of UV 
irradiation and ATR. In addition, the level of UV-induced Ser15-phosphorylation of p53 was 
lower in G-1 and G2-phase cells than in S-phase cells. Coincidently, DNA repair of UV-induced 
CPDs was much more efficient in S phase than in G1 phase. Interestingly, it was previously 
demonstrated that p53 deficiency had a negative impact on GG-NER but not on TC-NER (165, 
166). Given the indispensable role of XPA in both GG-NER and TC-NER, the observation of 
p53’s requirement for the UV-induced XPA nuclear import in S-phase cells implies that TC-
NER may predominately occur in other cell cycle phases in a p53-independent manner.  
Chapter 4: UV-Induced Nuclear Import of XPA Is Mediated by Importin-Alpha4 in an ATR-
Dependent Manner 
Due to its indispensable role in human NER, including both global genome and 
transcription-coupled NER subpathways, XPA may serve as a potential target for sensitization to 
cancer chemotherapy (e.g. cisplatin) via manipulation of available nuclear XPA, either at the 
transcriptional or posttranscriptional level (73, 78-80, 123). So far we have demonstrated that 
DNA damage-induced nuclear import of cytoplasmic XPA for NER in S-phase cells is a DNA 
damage checkpoint-dependent process mediated by ATR and p53 (Chapter 3). It remains 
unresolved to us how XPA is imported into the nucleus through the nuclear pore complex (NPC). 
Understanding of this XPA nuclear importation could be important because targeting protein 
trafficking is a potential strategy to improve the sensitivity of cancer cells to chemotherapeutic 
agents (137). The goal of the work presented in Chapter 4 was to identify the transporters that are 
responsible for the UV-induced nuclear import of XPA. The observation that the nuclear import 
of XPA depends on its NLS in cells excludes the possibility that XPA was coimported with other 
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proteins containing a NLS or imported by “alternative import mechanisms” (more than one 
mechanism) (136).  
Our data also indicate that the same NLS is used by different adaptors, importin-α4 
and/or importin-α7, for transporting XPA through the NPC. Although both importin-α4 and 
importin-α7 are required for XPA nuclear import, the requirement of importin-α4 is mediated by 
ATR in DNA damage-dependent manner while that of importin-α7 is not. Interestingly, the NLS 
of XPA could not be efficiently recognized by importin-α4 in the absence of UV-irradiation. 
This is likely due to the masking of the XPA NLS by the binding of other cytoplasmic factors 
(187, 189). This hypothesis is validated by the observation that importin-α4 immunoprecipitated 
from both UV- and mock-treated cell lysates could bind recombinant XPA protein in vitro. 
Elucidation of the details as to which cytoplasmic factors might mask the NLS and thus regulate 
this interaction merits future investigation. The binding of importin-α4 to XPA is largely induced 
by UV-irradiation within ½ hour after exposure. This suggests that the efficient nuclear import of 
XPA may occur as early as ½ hour post-UV-irradiation which is consistent with our previous 
report (74). In contrast, substantial XPA-importin-α7 interaction was observed in the absence of 
DNA damage and, thus, the DNA damage appeared to have no effect on the interaction. Given 
that a small portion of XPA is present in the nucleus even without DNA damage, a possible 
scenario is that importin-α7 could be involved in the nuclear import of XPA independent of 
DNA damage while importin-α4 could participate in the damage-dependent import of XPA. 
Additionally, we have shown that the DNA damage-induced nuclear import of XPA is cell cycle 
dependent, primarily occurring in S phase (135).  In G2-phase cells, XPA is localized to the 
nucleus regardless of DNA damage (135). Thus, it is possible that importin-α7 is mainly 
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responsible for nuclear import of XPA in G2 phase while importin-α4 is for XPA nuclear import 
during S phase. 
Finally, XPA binding protein 1 is a GTP-binding protein that was identified as an 
interacting partner with XPA in the yeast 2-hybrid system; it was proposed as the GTPase 
involved in XPA nuclear import (172). However, our results show that siRNA knockdown of 
XAB1 had no effect on the UV-induced nuclear import of XPA. This inconsistency could be due 
to the different environments within human cells and the yeast model system.  
Chapter 5: Differential DNA Damage Responses in p53 Proficient and Deficient Cells: Cisplatin-
Induced Nuclear Import of XPA Is Independent on ATR Checkpoint in p53-Deficient Lung 
Cancer Cells (138) 
One of the major challenges in treating cancer patients with cisplatin is the drug’s side-
effects: it introduces DNA damage to cancer cells while also causing damage to normal cells 
(140). One solution for this problem is to identify mechanistic differences of DNA damage 
responses between normal and cancer cells. In the current study effort was made to define the 
unique mechanism of DNA damage responses in p53-deficient lung cancer cells as p53 is the 
most commonly mutated gene in human cancers, particularly the lung cancer. Thus 3 cell lines 
including the human normal primary cell line BJ, the p53-proficient lung cancer cell line A549, 
and the p53-deficient lung cancer cell line H1299 were treated with cisplatin or UV-C 
irradiation. A pronounced cytoplasm-to-nucleus translocation of XPA was observed in each of 
these cell lines, which is consistent with our previous observations on other types of cells treated 
with UV. Importantly, however, different from p53-proficient cells the damage-induced XPA 
import is not dependent on ATR or other major known checkpoints in the p53-deficient lung 
cancer cells-H1299 (Figure 5-2 and Figure 5-3). These observations reveal a mechanistic 
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difference of DNA damage responses between p53-proficient and p53-deficient lung cancer 
cells. This finding provides a possibility to specifically target this unknown pathway to sensitize 
the cisplatin-induced killing effects in p53-deficent cancer cells by inhibiting the DNA damage 
induced nuclear import of XPA. Evidently, identifying the novel regulation mechanism 
responsible for the damage-induced XPA import in the p53-deficient cancer cells deserves 
further investigation. 
Chapter 6: Cytoplasmic ATR Lacking Checkpoint Kinase Activity is a Bax Inhibiting 
Antiapoptosis Protein at Mitochondria 
  ATR has been shown to have antiapoptotic functions (58, 101-105, 144) and has drawn 
attention as a promising target for anticancer chemotherapy. However, it was not clear to us how 
ATR carries out its intrinsic antiapoptotic roles. We reasoned that ATR may have a role in the 
mitochondria-mediated apoptotic pathways. As a novel finding (Chapter 6), our results revealed 
a kinase-independent antiapoptotic function of ATR through inhibition of the Bax-mediated 
mitochondrial pathway during cellular responses to DNA damage. Our results indicate that, in 
addition to its checkpoint functions, ATR also has a direct role in suppressing mitochondria-
mediated apoptosis. ATR inhibits Bax-mediated loss of mitochondrial membrane potential, and 
the role of ATR in stabilizing mitochondrial ΔΨ does not depend on its kinase activity. Unlike 
nuclear ATR, cytoplasmic ATR lacks checkpoint kinase activity toward p53 or RPA. 
Additionally, nuclear ATR is activated primarily by replication stress-inducing DNA damage 
such as UV damage, whereas cytoplasmic ATR shows antiapoptotic activity in response to 
various types of DNA damage such as DNA double-strand breaks induced by CPT. These 
observations suggest that ATR has 2 distinct functions delivered by the 2 different forms of ATR 
during DNA damage. The nuclear ATR kinase is involved in activation of cell cycle checkpoints 
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and DNA repair while the cytoplasmic ATR stabilizes mitochondria, preventing activation of 
apoptosis. The synergetic action of these 2 events promotes the biological stability of the cells 
under the stress of DNA damage (Figure 7-1). Also, in unstressed conditions, ATR appears to be 
in a much lower level in the cytoplasm than in the nucleus. Although the cytoplasmic level of 
ATR might be increased via translation when DNA is damaged, our data appear to support an 
export of existing nuclear ATR. Indeed, given the large size (301 kDa) of the protein, nuclear 
export allows a much quicker response to DNA damage than does transcription followed by 
translation. 
 
 
 
Figure 7-1. A model for the major conclusions in this dissertation 
Another interesting observation of this study (Chapter 6) is that a new form of 
cytoplasmic ATR electrophoretically migrates slower than nuclear ATR in SDS-PAGE, 
implying that the occurrence of a possible posttranslational modification (PTM) to the protein. 
Although ATR is known to undergo phosphorylation upon DNA damage (70, 119), 
phosphorylation does not change the electrophoretic mobility of ATR (70, 119). In efforts to 
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characterize the slower migrating cytoplasmic ATR, we examined the possible PTMs including 
glycosylation, ubiquitinylation (which is required for translocation of p53 to mitochondria 
(213)), sumoylation, palmitoylation, and prenylation. Unfortunately, none of these modifications 
were found to be responsible for the slower electrophoretic mobility of cytoplasmic ATR. N-
myristoylation is also unlikely as the sequence of ATR contains no target amino acid for N-
myristoylation, although N-myristoylation happens on BID (BH3 interacting-domain death 
agonist) and is required for its mitochondria membrane association and proapoptotic functions 
(215).  Furthermore, protein translation inhibition by cycloheximide or puromycin had no effect 
on the formation of the cytoplasmic ATR following UV damage, which suggests that the nuclear 
ATR is not a proteolytic product of the slower migrating cytoplasmic ATR, assuming the latter 
to be the nascent ATR. The translation-inhibition data also indicate that, once formed, the 
cytoplasmic ATR is relatively stable. These results suggest that ATR might undergo an unknown 
DNA damage-induced molecular modification. The formation of the mitochondria ATR, as well 
as the mechanism by which ATR relocates to mitochondria, may represent a novel mechanism 
that cells have evolved to inhibit DNA damage-induced apoptosis. Identifying the modification, 
although out of the scope of this study, would be an important future effort to fully understand 
the role of ATR in DNA damage responses.   
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APPENDIX A 
 
ABBREVIATIONS 
  
(6-4)PP, (6-4) photoproduct  
9-1-1, Rad9-Rad1-Hus1 complex 
AT, ataxia telangiectasia  
ATM, Ataxia telangiectasia mutated  
ATP, adenosine triphosphate  
ATR, Ataxia telangiectasia mutated and RAD3-related  
ATRIP, ATR interacting protein 
Bad, Bcl-2-associated death promoter 
Bak, Bcl-2 homologous antagonist/killer 
Bax, Bcl-2–associated X protein 
BcL-2, B-cell lymphoma 2 
Bid, BH3 interacting-domain death agonist 
Bim, Bcl-2-like protein 11 
CS, Cockayne syndrome 
CSA, Cockayne syndrome A 
Chk1, checkpoint kinase-1 
Chk2, checkpoint kinase-2 
CHX, Cycloheximide 
CPD, cyclobutane pyrimidine dimer  
CPT, camptothecin  
Cyto, cytoplasm 
CytoC, cytochrome C 
DAPI, 4’,6-diamidino-2-phenylindole  
DBD, DNA binding domain  
DDB, damaged DNA binding protein 
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DDR, DNA damage response  
DMEM, Dulbecco’s modified Eagle’s medium 132 
DMSO, Dimethyl sulfoxide  
DNA-PKcs, DNA-dependent protein kinase catalytic subunit 
DTT, dithiothreitol 
EDTA, ethylenediaminetetraacetic acid 
ERCC1, excision repair cross complementation group 1 
FAT, FRAP/ATM/TRAP  
FBS, fetal bovine serum  
FANCD2, Fanconi anemia group D2 
GFP, green fluorescent protein  
GGR, global genome repair 
GST, Glutathione S-transferase  
HEAT, huntingtin, elongation factor 3, protein phosphatase 2A and yeast TOR1 
HSP70, heat shock protein 70 
HTH, helix-turn-helix  
HU, hydroxyurea 
IP, immunoprecipitation 
kDa, kilodalton 
Mcl-1, myeloid cell leukemia sequence 1 
MHSP70, mitochondria heat shock protein 70 
Mito, mitochondria  
MK2, MAPKAP Kinase-2 
MS, mass spectrometry  
MS/MS, tandem mass spectrometry 
mTOR, mammalian target of rapamycin 
NF-kB, nuclear factor-kB  
NER, nucleotide excision repair 
NLS, nuclear localization signal 
NPC, nuclear pore complex 
PAGE, polyacrylamide gel electrophoresis  
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PBS, phosphate buffered saline  
PDB, Protein Data Bank 133 
PI, propidium iodide 
PIKK, phosphatidylinsoitol 3-kinase-related kinase  
PARP, poly ADP ribose polymerase  
PTM, posttranslational modification 
PVDF, polyvinylidene difluoride 
RHINO, RAD9, HUS1, RAD1-interacting nuclear orphan protein  
RNAi, RNA interference 
RPA, replication protein A  
SDS-PAGE, sodium docecyl sulfate-polyacrylamide gel electrophoresis  
siRNA, small interfering ribonucleic acid  
ssDNA, single-stranded DNA 
SUMO, small ubiquitin-like modifier  
TCR, transcription coupled repair  
TFIIH, transcription factor II H  
TopBP1, DNA topoisomerase 2-binding protein 1 
TTD, trichothiodystrophy  
UB, ubiquitin 
UTR, untranslated region 
UV, ultraviolet  
UV-C, ultraviolet C  
XAB1, XPA binding protein1 
XP, Xeroderma pigmentosum  
XPA-G, Xeroderma pigmentosum complementation group A-G  
XPC-HR23B, Xeroderma pigmentosum complementation group C-human homolog of Rad23B 
ΔΨ, mitochondrial membrane potential   
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